Lichen simplex chronicus and prurigo

L12_LICHSIMPANDPRURIGO

neurodermatitis: an itchy skin disease similar to atopic dermatitis. It tends to result in focal patches—one or many—that are due to frequent rubbing or scratching of the same area over time.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L28 Cause of death: ICD-10 — L28 2 out of 7 registries used, show all original rules.	2845
4. Check minimum number of events None	2845
5. Include endpoints L12_LICHENSIMPLEX L12_PRURIGONOD L12_PRURIGONAS	2953
6. Filter based on genotype QC (FinnGen only)	2632

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L20-L30
Name in latin: Neurodermatitis

NAME	L12_LICHSIMPANDPRURIGO
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	L12_LICHENSIMPLEX\|L12_PRURIGONOD\|L12_PRURIGONAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L28
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L28
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Lichen simplex chronicus and prurigo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17097	9353	7639
Only index persons	15358	8556	6802
Unadjusted period prevalence (%)
Whole population	0.24	0.27	0.21
Only index persons	0.29	0.31	0.26
Median age at first event (years)
Whole population	56.19	56.86	55.37
Only index persons	55.35	55.98	54.56

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2632	1549	1083
Unadjusted period prevalence (%)	0.53	0.55	0.50
Median age at first event (years)	57.11	55.91	58.82

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2722: Matched controls
27220

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L29.9

ICD-10 Finland

Pruritus, unspecified

17.0

323.3

276

179

D07AB02

ATC

hydrocortisone butyrate; topical

4.4

314.9

1290

4622

L30.3

ICD-10 Finland

Infective dermatitis

27.6

307.7

323

132

D07BC01

ATC

betamethasone and antiseptics; topical

6.9

307.7

767

1462

TQW80

NOMESCO Finland

Local dermatologic skincare

31.5

307.7

362

132

L28.2

ICD-10 Finland

Other prurigo

574.1

307.7

437

D07AC13

ATC

mometasone; topical

7.5

307.7

1604

4374

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

10.5

307.7

748

944

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

66.3

307.7

242

L28.0

ICD-10 Finland

Lichen simplex chronicus

1416.6

307.7

1317

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

6.8

307.7

821

1633

L30.9

ICD-10 Finland

Dermatitis, unspecified

10.2

307.7

1277

2172

D07AD01

ATC

clobetasol; topical

14.3

307.7

1543

2283

E000001, ,

ATC

5.8

307.7

1020

2544

L20.0

ICD-10 Finland

Besnier prurigo

+∞

307.7

420

D07AC01

ATC

betamethasone; topical

10.2

307.7

2015

5951

L28

ICD-10 Finland

Lichen simplex chronicus and prurigo

38.4

307.7

203

L28.1

ICD-10 Finland

Prurigo nodularis

1496.9

307.7

966

XQ802

NOMESCO Finland

Epicutan test

26.9

307.7

252

103

D09AB01

ATC

zinc bandage without supplements; topical

69.0

307.7

543

E0000UV, ,

ATC

7.9

307.7

1977

6859

D07AB08

ATC

desonide; topical

6.5

300.9

571

1075

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

284.5

268

E000002, ,

ATC

5.7

248.5

536

1128

D07CC01

ATC

betamethasone and antibiotics; topical

4.9

245.7

656

1657

D07BA04

ATC

hydrocortisone and antiseptics; topical

5.7

238.2

503

1036

L30.0

ICD-10 Finland

Nummular dermatitis

11.4

234.2

254

244

D02AE01

ATC

carbamide; topical

6.7

215.7

375

638

D02AX

ATC

Other emollients and protectives

12.7

213.4

214

182

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

5.5

182.9

393

814

A46

ICD-10 Finland

Erysipelas

3.8

181.6

696

2257

R06AE07

ATC

cetirizine; oral

3.1

180.9

1544

8089

L29.8

ICD-10 Finland

Other pruritus

19.3

178.4

141

E000003, ,

ATC

7.3

154.2

237

351

XQ848

NOMESCO Finland

Dermatological photography

8.9

152.3

195

233

N05BB01

ATC

hydroxyzine; systemic

5.4

148.3

314

638

D07XC01

ATC

betamethasone; topical

3.8

148.2

526

1601

R06AX27

ATC

desloratadine; oral

2.9

144.7

1035

4784

E000007, ,

ATC

6.3

140.1

248

425

D07AA02

ATC

hydrocortisone; topical

3.7

137.7

516

1624

L30.8

ICD-10 Finland

Other specified dermatitis

9.9

126.6

149

159

H02AB06

ATC

prednisolone; systemic

2.6

124.9

1568

9390

E000006, ,

ATC

4.8

122.8

298

678

XQ800

NOMESCO Finland

Prick test

4.7

113.6

281

648

L20.8

ICD-10 Finland

Other atopic dermatitis

+∞

102.8

L20

ICD-10 Finland

Atopic dermatitis

+∞

99.6

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

+∞

98.5

R06AE09

ATC

levocetirizine; oral

3.0

98.5

524

2013

L40.0

ICD-10 Finland

Psoriasis vulgaris

5.2

98.3

210

427

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.5

96.3

782

3725

L50.3

ICD-10 Finland

Dermatographic urticaria

9.7

95.6

113

121

S02

ICPC

Pruritus

5.3

86.4

181

361

D05BB02

ATC

acitretin; oral

7.0

84.3

131

195

L04AX03

ATC

methotrexate; systemic

3.1

82.3

402

1462

S29

ICPC

Skin symptom/complaint other

2.4

76.7

696

3438

J01DB01

ATC

cefalexin; oral

2.9

76.2

2373

19161

D07AC14

ATC

methylprednisolone aceponate; topical

4.5

76.1

195

460

J01FF01

ATC

clindamycin; systemic

2.2

75.8

879

4810

S97

ICPC

Chronic ulcer skin

3.5

74.2

277

854

S87

ICPC

Dermatitis/atopic eczema

7.0

71.4

110

162

L43.0

ICD-10 Finland

Hypertrophic lichen planus

15.5

70.9

D05AX52

ATC

calcipotriol, combinations; topical

3.9

69.8

218

595

L43.9

ICD-10 Finland

Lichen planus, unspecified

6.3

68.0

116

190

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

64.8

456

1991

J01DA01

ATC

[U] cefalexin

2.0

64.7

1769

13011

D11AH01

ATC

tacrolimus; topical

139.4

64.2

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

63.5

1438

9884

L04AD01

ATC

ciclosporin; systemic

6.9

63.4

148

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.9

62.2

195

533

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

5.9

62.2

113

197

R06AX22

ATC

ebastine; oral

2.3

61.2

543

2628

S76

ICPC

Skin infection other

3.5

60.8

225

688

L13.0

ICD-10 Finland

Dermatitis herpetiformis

24.3

60.3

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.5

60.2

420

1823

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

+∞

58.5

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.8

57.1

107

192

C03CA01

ATC

furosemide; systemic

2.0

56.6

905

5469

69830

ICD-8 Finland

Pruritus and related conditions, Lichenification and lichen simplex chronicus

+∞

56.4

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

12.8

55.6

J04BA02

ATC

dapsone; oral

17.9

54.2

L43.8

ICD-10 Finland

Other lichen planus

5.8

54.2

100

177

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

20.8

54.0

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

52.3

447

2117

H02AB04

ATC

methylprednisolone; systemic

2.3

51.6

462

2232

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

50.5

876

5400

N02AX02

ATC

tramadol; systemic, rectal

1.8

47.6

1234

8583

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.7

47.2

153

427

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

47.2

581

3171

R03AC02

ATC

salbutamol; inhalant

1.8

46.8

1527

11343

J01CE08

ATC

benzathine benzylpenicillin; parenteral

7.8

45.9

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.0

45.6

100

207

S18

ICPC

Laceration/cut

1.8

45.6

1357

9786

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

455.2

45.4

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.7

43.8

103

226

L85.3

ICD-10 Finland

Xerosis cutis

7.8

43.4

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

81.5

43.0

6983B

ICD-9 Finland

Pruritus and related conditions, Lichenification and lichen simplex chronicus[NEURODERMATITIS CIRCUMSCRIPTA]

+∞

42.8

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

42.1

571

3211

J01CF05

ATC

flucloxacillin; systemic

2.7

42.0

245

967

L29

ICD-10 Finland

Pruritus

6.6

41.7

103

B86

ICD-10 Finland

Scabies

4.5

41.7

102

231

S21

ICPC

Skin texture symptom/complaint

2.1

41.2

465

2445

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.0

40.3

120

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.6

40.3

213

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

40.0

399

2000

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.8

39.9

214

808

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

39.9

268

1133

D07XB05

ATC

dexamethasone; topical

4.5

39.2

226

R06.0

ICD-10 Finland

Dyspnoea

1.8

39.1

788

5016

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

38.9

1145

8114

H02AB07

ATC

prednisone; oral

2.1

38.4

404

2065

E000004, ,

ATC

5.7

38.2

130

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

37.7

430

2264

M79.6

ICD-10 Finland

Pain in limb

1.7

37.6

1232

8959

R06AX13

ATC

loratadine; oral

2.1

37.5

421

2203

L04AA06

ATC

mycophenolic acid; systemic

4.8

37.2

182

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.4

36.9

134

403

R50.9

ICD-10 Finland

Fever, unspecified

2.0

36.6

445

2397

N03AX16

ATC

[U] pregabalin

1.8

36.5

658

4037

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

36.3

998

6909

L12.0

ICD-10 Finland

Bullous pemphigoid

11.4

35.4

L73.8

ICD-10 Finland

Other specified follicular disorders

7.2

35.2

D05AX02

ATC

calcipotriol; topical

3.4

35.1

132

406

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

35.1

368

1875

SPAT1263

SPAT

Sampling

1.7

35.0

1114

7992

UJF32

NOMESCO Finland

Coloscopy

1.8

35.0

741

4761

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

8.8

34.9

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

34.7

694

4383

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

34.7

312

1496

TK800

NOMESCO Finland

Hemodialysis

4.3

34.6

210

D11AX14

ATC

[U] tacrolimus

+∞

34.4

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.9

34.4

167

597

A11CC03

ATC

alfacalcidol; systemic

4.1

33.7

240

J01MA02

ATC

ciprofloxacin; systemic

1.7

33.6

1057

7538

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

33.6

706

4518

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.6

33.4

111

315

N06AX21

ATC

duloxetine; oral

2.1

33.0

359

1852

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

33.0

327

1628

R03DC03

ATC

montelukast; oral

1.9

32.8

465

2634

N06AA12

ATC

doxepin; systemic

2.8

32.7

173

648

L04AX01

ATC

azathioprine; systemic

3.1

32.6

139

462

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

32.5

754

4953

A10AE04

ATC

insulin glargine; parenteral

2.2

32.4

304

1481

ZY010

NOMESCO Finland

Hospital outpatient

2.9

32.3

162

590

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.1

32.2

349

1797

395

Kela drug reimbursment

Dupilumab

62.5

32.1

D01AE15

ATC

terbinafine; topical

2.4

32.1

228

987

R60.0

ICD-10 Finland

Localized oedema

2.0

31.9

381

2032

A10AB05

ATC

insulin aspart; parenteral

2.4

31.9

241

1072

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

31.9

1200

8918

A02BC02

ATC

pantoprazole; systemic

1.7

31.8

1877

15561

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

31.4

393

2130

127

Kela drug reimbursment

Transplant complication

4.9

30.9

141

J01DA09

ATC

[U] cefadroxil

1.7

30.8

707

4621

D07CB01

ATC

triamcinolone and antibiotics; topical

4.5

30.7

174

D11AH05

ATC

dupilumab; topical

46.8

30.6

Z94.0

ICD-10 Finland

Kidney transplant status

5.8

30.2

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.1

29.8

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

156.7

29.7

G47.3

ICD-10 Finland

Sleep apnoea

1.7

29.6

648

4172

L08.0

ICD-10 Finland

Pyoderma

7.1

29.3

D11AH02

ATC

pimecrolimus; topical

+∞

29.2

P01AB01

ATC

metronidazole; oral, rectal

1.6

28.8

1066

7833

L21.0

ICD-10 Finland

Seborrhoea capitis

8.5

28.8

L17

ICPC

Foot/toe symptom/complaint

1.6

28.7

838

5813

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

28.5

311

1602

SPAT1301

SPAT

No procedures

1.6

28.4

819

5660

D06AX01

ATC

fusidic acid; topical

2.2

28.1

258

1244

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

28.0

934

6684

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

6.4

27.8

B35.3

ICD-10 Finland

Tinea pedis

2.8

27.6

144

535

A10AB04

ATC

insulin lispro; parenteral

3.2

27.4

108

342

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

27.4

334

1790

N18.8

ICD-10 Finland

Other chronic renal failure

3.8

27.2

218

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

+∞

27.1

R02

ICPC

Shortness of breath/dyspnoea

1.9

27.1

389

2203

K02.1

ICD-10 Finland

Caries of dentine

1.6

27.0

1541

12425

Z3231

NOMESCO Finland

Registered nurse

1.7

27.0

712

4801

J02AC01

ATC

fluconazole; systemic

1.6

26.9

1005

7369

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

26.8

392

2232

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

3.2

26.7

109

353

SPAT1260

SPAT

Consultation of another employee

1.8

26.6

466

2807

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

26.5

692

4651

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

26.4

769

5309

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

26.4

207

934

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

26.4

319

1703

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.7

26.3

232

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.0

26.3

117

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

10.5

26.2

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

6.4

26.1

AA1AD

NOMESCO Finland

CT of head and brain

1.6

26.1

794

5539

D07AC03

ATC

desoximetasone; topical

4.5

26.0

142

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

73.4

25.8

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

4.7

25.7

131

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

25.7

377

2147

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

25.7

985

7248

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

25.6

272

1386

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.0

25.6

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

25.5

603

3943

C03DA01

ATC

spironolactone; oral

1.9

25.4

348

1937

M54.5

ICD-10 Finland

Low back pain

1.6

25.4

975

7169

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

25.3

1895

16116

A10AE05

ATC

insulin detemir; parenteral

2.5

25.3

160

655

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

25.3

529

3347

L50.9

ICD-10 Finland

Urticaria, unspecified

3.0

25.2

115

397

SPAT1262

SPAT

Handing over of treatment supplies

1.8

25.2

469

2870

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

25.2

683

4626

N02BE01

ATC

paracetamol; systemic, rectal

1.9

25.0

2416

21916

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

25.0

769

5370

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

24.9

619

4097

J01MA12

ATC

levofloxacin; systemic

1.7

24.9

497

3103

N06AB04

ATC

citalopram; systemic

1.7

24.8

551

3541

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

24.7

138

531

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.8

24.7

124

452

L98.1

ICD-10 Finland

Factitial dermatitis

43.3

24.6

I50.0

ICD-10 Finland

Congestive heart failure

2.2

24.5

205

951

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

24.3

633

4237

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.8

24.3

198

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

24.3

475

2947

J01AA02

ATC

doxycycline; systemic

1.6

24.2

2066

18005

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

24.1

240

1193

A10AC01

ATC

insulin (human); parenteral

2.2

23.9

213

1013

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

23.8

373

2165

N05CF01

ATC

zopiclone; oral

1.6

23.8

843

6068

137

Kela drug reimbursment

Uraemia requiring dialysis

6.1

23.8

WW200

NOMESCO Finland

Immunization

3.2

23.7

299

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

23.7

1718

14393

E66.8

ICD-10 Finland

Other obesity

2.4

23.7

166

713

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

6.2

23.6

L04AA01

ATC

[U] ciclosporin

4.8

23.6

112

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

23.6

183

822

T90

ICPC

Diabetes non-insulin dependent

1.6

23.5

663

4521

A02BC03

ATC

lansoprazole; oral

1.6

23.5

752

5286

M79.7

ICD-10 Finland

Fibromyalgia

2.9

23.3

110

387

N06AX11

ATC

mirtazapine; oral

1.5

23.3

901

6605

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

23.2

327

1835

SPAT1310

SPAT

Counselling related to known health issue

1.6

23.1

805

5765

C07AB07

ATC

bisoprolol; oral

1.5

23.0

1283

10156

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

22.8

311

1726

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

22.8

129

500

N03AX12

ATC

[U] gabapentin; oral

1.7

22.7

433

2663

B05DA

ATC

Isotonic solutions

6.6

22.6

B05DB

ATC

Hypertonic solutions

7.0

22.5

R03BA05

ATC

fluticasone; inhalant

1.7

22.4

463

2910

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

22.4

460

2888

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

22.3

201

960

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

22.1

493

3163

L26

ICD-10 Finland

Exfoliative dermatitis

+∞

21.9

N06AX16

ATC

venlafaxine; oral

1.8

21.7

376

2246

Z49.2

ICD-10 Finland

Other dialysis

6.6

21.7

A12AA04

ATC

calcium carbonate; oral

4.2

21.7

137

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

21.6

480

3073

SFA30

NOMESCO Finland

Three-surface restoration

1.5

21.6

1122

8715

A10BA02

ATC

metformin; oral

1.6

21.6

745

5308

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

116.0

21.6

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

116.0

21.6

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

21.4

1042

7988

S88

ICPC

Dermatitis contact/allergic

3.9

21.4

165

V03AE02

ATC

sevelamer; oral

7.9

21.3

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

21.2

216

1082

EBA00

NOMESCO Finland

Extraction of tooth

1.5

21.2

939

7056

D07AB01

ATC

clobetasone; topical

3.1

21.1

299

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.5

20.9

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

20.8

257

1379

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

20.8

1625

13639

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

20.7

298

1682

SPAT1255

SPAT

Intravenous administration of medicine

2.2

20.7

191

921

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.8

20.5

101

364

L28

ICPC

Limited function/disability (L)

1.6

20.5

511

3367

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

20.4

1415

11586

A02BC05

ATC

esomeprazole; systemic

1.5

20.2

1053

8156

S06

ICPC

Rash localized

2.3

20.2

159

719

R53

ICD-10 Finland

Malaise and fatigue

1.6

20.1

646

4518

R03BA02

ATC

budesonide; inhalant

1.7

20.1

450

2883

Z2446

NOMESCO Finland

Social worker

2.2

19.9

173

814

R03BB04

ATC

tiotropium bromide; inhalant

1.9

19.9

267

1473

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

19.9

1120

8798

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

3.4

19.8

217

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

36.0

19.8

M25.5

ICD-10 Finland

Pain in joint

1.5

19.8

857

6387

6983A

ICD-9 Finland

Pruritus and related conditions, Lichenification and lichen simplex chronicus[PRURIGO NODULARIS HYDE]

+∞

19.8

S01

ICPC

Pain/tenderness of skin

2.4

19.7

142

618

K08.3

ICD-10 Finland

Retained dental root

2.0

19.6

218

1127

N06AA09

ATC

amitriptyline; systemic

1.9

19.6

256

1399

SPAT1153

SPAT

Removal of sutures

1.5

19.6

800

5890

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

19.5

820

6071

A06AD11

ATC

lactulose; oral

1.7

19.5

382

2361

A03

ICPC

Fever

1.7

19.5

419

2656

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

19.4

210

1075

J45

ICD-10 Finland

Asthma

1.9

19.4

270

1507

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.3

19.4

SPAT1254

SPAT

Administration of medicine

1.7

19.4

380

2349

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

19.3

242

1304

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

19.2

160

740

L03.9

ICD-10 Finland

Cellulitis, unspecified

3.4

19.2

202

L43

ICD-10 Finland

Lichen planus

4.5

19.2

107

L29.2

ICD-10 Finland

Pruritus vulvae

4.6

19.2

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

19.1

963

7386

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

19.1

1848

16029

SFA10

NOMESCO Finland

One-surface restoration

1.4

18.9

1400

11537

J01FA06

ATC

roxithromycin; oral

1.5

18.9

1006

7795

A02BC01

ATC

omeprazole; systemic

1.5

18.9

692

4973

J01AA07

ATC

tetracycline; systemic

1.7

18.9

352

2145

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

18.8

172

826

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

18.8

194

977

R03BA01

ATC

beclometasone; inhalant

1.7

18.5

356

2187

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

18.5

173

839

L04AD02

ATC

tacrolimus; systemic

4.5

18.5

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

18.4

206

1068

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

18.4

967

7467

S99

ICPC

Skin disease other

3.3

18.3

213

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.9

18.3

137

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

18.3

343

2092

M04AA01

ATC

allopurinol; systemic

1.8

18.3

326

1961

A01AB09

ATC

miconazole; local oral

1.9

18.2

225

1206

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

18.1

186

934

H3603, E103,

ICD-10 Finland

5.1

18.1

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.7

18.0

Z71.8

ICD-10 Finland

Other specified counselling

1.5

17.9

854

6462

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

17.9

125

536

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

17.9

256

1440

R06AX18

ATC

acrivastine; oral

2.9

17.9

290

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

17.9

100

386

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

17.8

583

4080

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

+∞

17.7

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

17.7

1163

9339

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

17.6

348

2154

C08CA13

ATC

lercanidipine; oral

1.7

17.4

389

2484

L29.0

ICD-10 Finland

Pruritus ani

5.9

17.4

R42

ICD-10 Finland

Dizziness and giddiness

1.5

17.4

592

4178

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.2

17.4

147

685

SFA20

NOMESCO Finland

Two-surface restoration

1.4

17.3

1482

12452

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.9

17.3

134

UKC02

NOMESCO Finland

Cystoscopy

1.6

17.2

393

2526

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.4

17.1

177

J46

ICD-10 Finland

Status asthmaticus

2.8

17.1

303

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

17.0

306

1843

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

17.0

288

1706

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

16.9

600

4270

N05AH04

ATC

quetiapine; oral

1.6

16.9

436

2887

205

Kela drug reimbursment

Chronic hypertension

1.5

16.8

657

4769

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

+∞

16.7

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

16.7

481

3268

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.8

16.6

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

16.6

463

3119

S91

ICPC

Psoriasis

4.9

16.6

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

16.4

385

2489

M10.9

ICD-10 Finland

Gout, unspecified

2.0

16.3

181

935

N05BA04

ATC

oxazepam; oral

1.5

16.3

659

4812

RJ411, ,

NOMESCO Finland

6.3

16.3

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.3

16.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

16.3

665

4865

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

16.2

695

5132

R11

ICD-10 Finland

Nausea and vomiting

1.9

16.2

230

1290

L30.4

ICD-10 Finland

Erythema intertrigo

4.3

16.2

R52.9

ICD-10 Finland

Pain, unspecified

1.8

16.2

265

1553

J45.8

ICD-10 Finland

Mixed asthma

2.7

16.1

324

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

16.1

196

1046

B03BA03

ATC

hydroxocobalamin; parenteral

2.1

16.1

146

700

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

16.0

120

531

WQ020, ,

NOMESCO Finland

47.8

16.0

D01AC02

ATC

miconazole; topical

1.9

16.0

193

1026

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

3.9

16.0

123

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

16.0

372

C08CA01

ATC

amlodipine; oral

1.4

16.0

989

7815

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

16.0

209

1142

N06AB03

ATC

fluoxetine; oral

1.7

15.9

310

1907

S06.0

ICD-10 Finland

Concussion

1.8

15.9

278

1659

WX290

NOMESCO Finland

Other blockage of nerve

1.4

15.9

1157

9401

N18.0

ICD-10 Finland

End-stage renal disease

4.6

15.9

R52.2

ICD-10 Finland

Other chronic pain

2.4

15.9

111

477

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

6.6

15.7

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

15.7

332

2089

69820

ICD-8 Finland

Pruritus and related conditions, Prurigo

+∞

15.6

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

15.6

159

796

A10BH01

ATC

sitagliptin; oral

1.8

15.6

252

1470

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

15.6

137

648

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

26.4

15.6

K07

ICPC

Swollen ankles/oedema

2.2

15.5

133

624

TGC00

NOMESCO Finland

Bronchial lavation

2.8

15.5

269

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

15.4

177

925

J01FA01

ATC

erythromycin; systemic

1.7

15.4

313

1947

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

15.4

172

891

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.8

15.4

270

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

15.3

178

934

M48.0

ICD-10 Finland

Spinal stenosis

1.7

15.3

325

2046

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

15.3

142

687

WZC30

NOMESCO Finland

Teaching

1.6

15.2

428

2886

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

15.2

216

1212

R96

ICPC

Asthma

1.8

15.2

259

1535

SPAT1229

SPAT

Assessment of need for aid

1.9

15.2

195

1059

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

15.2

132

622

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

15.2

463

3180

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.7

15.2

264

1574

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

15.1

191

1031

L03

ICPC

Low back symptom/complaint

1.4

15.1

740

5592

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

15.1

169

875

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.8

15.1

119

L50.8

ICD-10 Finland

Other urticaria

3.5

15.1

152

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

15.1

166

855

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

15.1

452

3092

WQ021, ,

NOMESCO Finland

45.3

15.1

N02BF01

ATC

gabapentin; oral

1.7

15.0

284

1732

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.8

14.9

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

14.9

1071

8654

R51.80

ICD-10 Finland

Headache

1.6

14.9

380

2504

A10AE06

ATC

insulin degludec; parenteral

2.4

14.9

416

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.6

14.9

344

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

14.8

1297

10822

J01CA04

ATC

amoxicillin; systemic

1.5

14.8

2093

18929

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

14.8

403

2696

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

14.8

708

5326

H3601, E103,

ICD-10 Finland

5.0

14.8

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

14.8

628

4618

A10BK03

ATC

empagliflozin; oral

1.7

14.7

280

1711

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

14.7

566

4080

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

14.7

406

E0001A1, ,

ATC

3.5

14.7

145

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

14.6

322

2045

SPAT1284

SPAT

Extensive health certificate

2.8

14.6

266

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

14.6

217

1234

P01BA02

ATC

hydroxychloroquine; oral

1.8

14.6

211

1190

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

14.6

353

EB1VA, ,

NOMESCO Finland

1.5

14.6

454

3130

RJ420, ,

NOMESCO Finland

6.4

14.6

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

14.5

720

5447

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

14.5

404

2715

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

14.5

209

1177

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

5.0

14.5

SPAT1211

SPAT

Application of soft bandage

1.8

14.5

216

1230

F34.1

ICD-10 Finland

Dysthymia

2.4

14.5

415

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

14.5

377

2495

J04AB02

ATC

rifampicin; systemic

3.8

14.4

114

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

14.4

171

905

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

14.4

1686

14719

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

14.3

216

1234

J01AA04

ATC

lymecycline; systemic

1.7

14.3

292

1819

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

14.3

345

D01BA02

ATC

terbinafine; oral

1.5

14.3

623

4602

WX002

NOMESCO Finland

Sedation and analgesia

1.5

14.1

475

3328

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.6

14.1

125

L04AA13

ATC

[U] leflunomide

2.7

14.1

277

T89

ICPC

Diabetes insulin dependent

2.3

14.1

110

496

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

14.1

118

548

N02BF02

ATC

pregabalin; oral

1.9

14.1

179

969

L30

ICD-10 Finland

Other dermatitis

3.0

14.0

201

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

14.0

666

4997

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

14.0

670

5033

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

14.0

357

2351

KMAK, ,

NOMESCO Finland

1.4

14.0

1233

10267

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

14.0

118

550

B01AB05

ATC

enoxaparin; parenteral

1.4

13.9

783

6051

QDB10, ,

SPAT

2.6

13.9

314

SPAT1151

SPAT

Treatment of major wounds

4.0

13.9

A28

ICPC

Limited function/disability NOS

1.5

13.8

455

3171

A10AB01

ATC

insulin (human); parenteral

2.4

13.8

375

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

13.8

244

1462

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

2.4

13.7

425

V03AE01

ATC

polystyrene sulfonate; oral

3.7

13.6

114

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

13.6

105

472

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

+∞

13.5

M03BX02

ATC

tizanidine; oral

1.4

13.5

1550

13415

A04

ICPC

Weakness/tiredness general

1.6

13.5

388

2625

L40

ICD-10 Finland

Psoriasis

3.0

13.5

200

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

13.4

202

1153

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

13.4

154

806

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

13.4

320

2074

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

18.3

13.4

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

13.4

1175

9756

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

13.3

229

1361

5613

FHL

Conjunctival occlusion

6.3

13.3

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

13.3

119

568

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

13.3

466

3291

WZC00, ,

SPAT

1.6

13.3

370

2486

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

5.3

13.2

E66.9

ICD-10 Finland

Obesity, unspecified

2.3

13.2

420

K90.0

ICD-10 Finland

Coeliac disease

2.5

13.2

316

SPAT1312

SPAT

General health counselling

1.4

13.2

734

5653

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

13.2

133

664

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

13.2

281

1769

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

13.1

556

4078

C02AC05

ATC

moxonidine; oral

2.1

13.0

125

613

R03AC03

ATC

terbutaline; inhalant

1.6

13.0

324

2121

L50.0

ICD-10 Finland

Allergic urticaria

2.8

12.9

238

W19

ICD-10 Finland

Unspecified fall

1.7

12.9

244

1487

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

12.9

178

989

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

12.8

438

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.1

12.8

174

-1, ,

NOMESCO Finland

1.4

12.8

768

5986

H01

ICPC

Ear pain/earache

1.7

12.8

270

1695

R05

ICD-10 Finland

Cough

1.5

12.8

522

3797

XQ845

NOMESCO Finland

Dermatoscopy

3.2

12.8

164

S19

ICPC

Skin injury other

2.2

12.7

101

459

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.8

12.7

SPAT1240

SPAT

Therapeutic discussion

1.7

12.7

230

1386

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.8

12.7

235

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

12.7

107

499

WX213

NOMESCO Finland

Lower leg blockade

4.3

12.7

C09AA02

ATC

enalapril; systemic

1.5

12.6

459

3261

Z2221

NOMESCO Finland

Medical doctor

1.4

12.6

644

4881

0350X

ICD-9 Finland

Erysipelas[ERYSIPELAS ALIA DEFINITA SEU NUD]

4.6

12.6

R04.0

ICD-10 Finland

Epistaxis

1.8

12.6

191

1094

SPAT1216

SPAT

Assessment of functional ability

1.5

12.6

376

2565

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

12.5

327

2163

A02BA02

ATC

ranitidine; systemic

1.5

12.5

455

3234

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

12.4

232

1409

R06AX26

ATC

fexofenadine; oral

1.9

12.4

160

871

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.7

12.4

103

R01AD09

ATC

mometasone; nasal

1.3

12.4

1082

8944

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

12.2

229

1392

Z01.2

ICD-10 Finland

Dental examination

1.3

12.2

1132

9430

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

12.2

260

1635

A08

ICPC

Swelling

1.9

12.2

151

810

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

12.1

855

6829

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

12.1

173

972

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.4

12.1

336

JN4AD

NOMESCO Finland

Body CT examination

1.6

12.1

287

1855

J01MA14

ATC

moxifloxacin; systemic

1.7

12.1

212

1266

C10AA05

ATC

atorvastatin; oral

1.3

12.1

1065

8804

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

12.1

373

2561

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

12.1

618

4681

B03XA02

ATC

darbepoetin alfa; parenteral

2.7

12.0

236

TK810

NOMESCO Finland

Hemofiltration

5.3

12.0

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.3

12.0

196

Kela drug reimbursment

Paricalcitol and cinacalcet

5.7

11.9

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

11.9

165

918

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.7

11.9

101

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

13.4

11.9

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

11.9

539

3991

Z3226

NOMESCO Finland

Physiotherapist

1.5

11.9

436

3100

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.6

11.9

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.1

11.8

107

513

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

11.8

273

A99

ICPC

Disease/condition unspecnature/site

1.6

11.8

266

1697

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

11.8

385

2674

R4110

NOMESCO Finland

Physiotherapy

1.4

11.7

681

5266

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.3

11.7

410

V03AE03

ATC

lanthanum carbonate; oral

9.0

11.7

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

11.7

463

L40.8

ICD-10 Finland

Other psoriasis

4.6

11.6

L15

ICPC

Knee symptom/complaint

1.4

11.6

627

4788

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

12.6

11.6

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

65.2

11.6

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.6

11.6

264

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.3

11.5

128

R01AD08

ATC

fluticasone; nasal

1.4

11.5

665

5138

SPAT1097

SPAT

Recording of ECG

1.5

11.5

344

2345

J01EA01

ATC

trimethoprim; systemic

1.4

11.5

613

4672

69798

ICD-8 Finland

Lichen, Alius definitus

+∞

11.5

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.6

11.4

254

N06AX12

ATC

bupropion; oral

1.8

11.4

158

880

C09CA01

ATC

losartan; oral

1.4

11.4

636

4883

N05BA01

ATC

diazepam; systemic, rectal

1.6

11.4

307

2044

L84

ICD-10 Finland

Corns and callosities

2.2

11.3

429

C08CA05

ATC

nifedipine; systemic

1.9

11.3

141

759

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

11.3

530

3949

A10BJ06

ATC

semaglutide; parenteral

1.9

11.3

140

753

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.2

11.2

411

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.3

11.2

360

N30.0

ICD-10 Finland

Acute cystitis

1.5

11.2

410

2912

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

11.2

874

7074

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

4.5

11.2

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.1

11.2

103

498

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

11.2

580

4397

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

11.2

151

835

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

11.1

501

3702

S02CA02

ATC

flumetasone and antiinfectives; otic

1.9

11.1

132

699

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

11.1

171

984

N05AX08

ATC

risperidone; systemic

1.7

11.0

204

1236

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

11.0

317

2141

N06AB05

ATC

paroxetine; oral

1.9

11.0

139

752

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.6

11.0

296

1970

U07

ICPC

Urine symptom/complaint other

1.7

11.0

215

1323

H02AB09

ATC

hydrocortisone; systemic

2.6

11.0

242

M01AE02

ATC

naproxen; oral, rectal

1.3

10.9

1367

11821

L01BA01

ATC

methotrexate; systemic

2.2

10.9

429

J02AC02

ATC

itraconazole; systemic

1.5

10.9

402

2858

N06AB10

ATC

escitalopram; oral

1.4

10.9

463

3383

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

10.9

253

1625

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

10.9

522

3899

XKD00

NOMESCO Finland

Uroflowmetry

1.5

10.8

340

2340

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

10.8

123

642

ZXA10

NOMESCO Finland

Bilateral

1.5

10.8

424

3052

ZXA05

NOMESCO Finland

Left side

1.4

10.8

578

4401

X58

ICD-10 Finland

Exposure to other specified factors

1.5

10.8

345

2383

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

10.8

789

6318

ACC51

NOMESCO Finland

Release of median nerve

1.7

10.7

191

1145

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

10.7

721

5696

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

10.7

341

2353

R35

ICD-10 Finland

Polyuria

1.8

10.7

166

957

D07XB01

ATC

flumetasone; topical

4.6

10.7

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.0

10.7

110

554

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

10.7

293

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.5

10.7

257

H04AA01

ATC

glucagon; nasal, parenteral

2.7

10.7

199

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

10.7

440

RD210, ,

NOMESCO Finland

2.9

10.7

166

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.4

10.7

312

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.1

10.6

145

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.8

10.6

194

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.7

10.6

211

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

10.6

225

1414

D06

ICPC

Abdominal pain localized other

1.7

10.6

213

1320

RS221, ,

NOMESCO Finland

3.2

10.6

130

K13.29

ICD-10 Finland

Indefinite leukoplakia

3.2

10.5

125

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.9

10.5

129

691

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.2

10.5

378

SPAT1283

SPAT

Restricted health certificate

1.5

10.5

333

2298

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

10.4

104

518

69899

ICD-8 Finland

Pruritus and related conditions, Other pruritic conditions

+∞

10.4

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

+∞

10.4

R74

ICPC

Upper respiratory infection acute

1.4

10.4

732

5819

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

10.4

168

981

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

10.4

236

1509

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

10.4

223

1406

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

10.4

108

547

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.8

10.4

191

P29

ICPC

Psychological sympt/compl other

1.8

10.3

162

937

U02

ICPC

Urinary frequency/urgency

1.5

10.3

359

2522

Z00.8

ICD-10 Finland

Other general examinations

1.7

10.3

191

1159

L71.9

ICD-10 Finland

Rosacea, unspecified

2.5

10.3

268

L21

ICD-10 Finland

Seborrhoeic dermatitis

3.0

10.3

148

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

10.3

178

1060

ZXE00

NOMESCO Finland

One hour or less

1.3

10.2

910

7485

R4120

NOMESCO Finland

Occupational therapy

1.8

10.2

166

970

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.3

10.2

337

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

10.2

229

1459

OAB50, ,

SPAT

1.7

10.2

205

1270

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

10.2

249

1619

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

10.2

297

2011

N19

ICD-10 Finland

Unspecified kidney failure

2.1

10.2

455

A10BJ02

ATC

liraglutide; parenteral

2.3

10.2

344

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

7.5

10.2

L12

ICPC

Hand/finger symptom/complaint

1.5

10.2

409

2957

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

10.2

195

1194

WVA30, ,

SPAT

1.8

10.1

165

966

SPAT1285

SPAT

Provision of consultation response

1.9

10.1

125

672

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.2

10.1

384

R03DC01

ATC

zafirlukast; oral

3.1

10.1

139

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.8

10.1

177

ZXD05

NOMESCO Finland

Urgent procedure

1.4

10.1

677

5342

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

10.1

179

1074

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.3

10.0

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

5.0

10.0

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

10.0

203

1260

PHD99

NOMESCO Finland

Resection of other vein

1.8

10.0

148

841

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

10.0

176

1053

D11

ICPC

Diarrhoea

1.6

10.0

273

1823

L14

ICPC

Leg/thigh symptom/complaint

1.7

9.9

199

1232

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

9.9

199

1233

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

9.9

234

1510

R05

ICPC

Cough

1.4

9.9

587

4540

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

9.9

148

845

49300

ICD-8 Finland

Asthma, bronchiale

2.6

9.9

225

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

9.9

270

1803

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

9.8

121

649

N17

ICPC

Vertigo/dizziness

1.5

9.8

317

2193

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

8.1

9.8

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

9.8

489

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.6

9.8

226

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

9.8

363

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

9.8

485

3640

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

9.8

230

1483

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

9.8

193

1191

C01CA24

ATC

epinephrine; parenteral

1.9

9.8

131

723

R06.5

ICD-10 Finland

Mouth breathing

1.6

9.7

213

1349

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

9.7

112

588

L01

ICD-10 Finland

Impetigo

3.3

9.7

106

SBA00

NOMESCO Finland

Microbiological examinations

2.3

9.7

294

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

9.7

707

5642

R4190

NOMESCO Finland

Nutritional therapy

2.1

9.7

464

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.4

9.7

N06AX26

ATC

vortioxetine; oral

1.7

9.6

166

987

H05BX01

ATC

cinacalcet; oral

4.2

9.6

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.2

9.6

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

9.6

107

555

D01

ICPC

Abdominal pain/cramps general

1.5

9.6

287

1953

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

9.6

459

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

9.6

180

1096

ZXA00

NOMESCO Finland

Right side

1.4

9.6

618

4841

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.4

9.5

253

J05AB01

ATC

aciclovir; systemic

1.4

9.5

504

3822

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

9.5

737

5930

S08

ICPC

Skin colour change

1.8

9.5

135

758

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

9.5

109

571

N06AB06

ATC

sertraline; oral

1.6

9.5

250

1654

L08

ICPC

Shoulder symptom/complaint

1.4

9.5

562

4341

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.8

9.5

R13

ICD-10 Finland

Dysphagia

1.7

9.5

174

1053

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.3

9.5

291

QXB99, ,

SPAT

2.2

9.5

355

M01AH02

ATC

rofecoxib; oral

1.5

9.4

292

2002

K59.0

ICD-10 Finland

Constipation

1.8

9.4

130

724

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

9.4

425

3136

Z00.0

ICD-10 Finland

General medical examination

1.4

9.4

444

3302

NHQ40

NOMESCO Finland

Amputation of toe

2.9

9.4

145

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

+∞

9.4

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

9.4

321

2248

R06AE08, ,

ATC

3.8

9.3

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

9.3

131

734

3025

Kela drug reimbursment

Calcium carbonate

4.7

9.3

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

9.3

226

1469

SPAT1252

SPAT

Overall medication plan or its review

1.7

9.3

155

914

P01

ICPC

Feeling anxious/nervous/tense

1.6

9.3

252

1680

L03

ICD-10 Finland

Cellulitis

3.7

9.3

A10BB12

ATC

glimepiride; oral

1.7

9.3

152

892

G44.2

ICD-10 Finland

Tension-type headache

1.5

9.2

309

2153

B07.9

ICD-10 Finland

Verruca simplex

2.1

9.2

405

M01AH01

ATC

celecoxib; oral

1.4

9.2

413

3043

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

7.3

9.2

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

9.2

375

2717

H03AA01

ATC

levothyroxine sodium; systemic

1.4

9.2

542

4184

ZX120

NOMESCO Finland

Intravenous

1.6

9.1

219

1418

N05CD07

ATC

temazepam; oral

1.5

9.1

256

1718

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.6

9.1

210

L71.8

ICD-10 Finland

Other rosacea

2.9

9.1

142

D01AC03

ATC

econazole; topical

1.8

9.1

141

813

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.0

9.1

126

G04BD12

ATC

mirabegron; oral

1.5

9.1

286

1967

A41.8

ICD-10 Finland

Other specified sepsis

2.7

9.1

187

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

9.1

296

2051

EBA30

NOMESCO Finland

Extraction of root of tooth

1.7

9.1

149

874

F60.8

ICD-10 Finland

Other specific personality disorders

4.6

9.1

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.6

9.1

RS220, ,

NOMESCO Finland

3.2

9.0

111

A29

ICPC

General symptom/complaint other

1.5

9.0

322

2272

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.9

9.0

143

QXA70

NOMESCO Finland

Guidance related to rash and skin care

36.8

9.0

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.4

9.0

260

J01FA09

ATC

clarithromycin; systemic

1.3

9.0

716

5777

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.1

8.9

417

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

8.9

183

1141

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.1

8.9

364

J01XC01

ATC

fusidic acid; systemic

3.2

8.9

107

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.7

8.9

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

8.9

630

4999

L52

ICD-10 Finland

Erythema nodosum

4.5

8.8

L88

ICPC

Rheumatoid/seropositive arthritis

1.9

8.8

103

544

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.2

8.8

333

T78.3

ICD-10 Finland

Angioneurotic oedema

3.1

8.8

113

H3600, E103,

ICD-10 Finland

3.4

8.8

R1250

NOMESCO Finland

Evaluation of functional capability

2.3

8.8

295

F29

ICPC

Eye symptom/complaint other

1.5

8.7

245

1645

A10BH05

ATC

linagliptin; oral

1.8

8.7

119

661

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.5

8.7

215

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

8.7

274

1885

A10AD01

ATC

insulin (human); parenteral

2.8

8.7

157

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.3

8.7

296

A01

ICPC

Pain general/multiple sites

1.5

8.7

245

1647

N03AE01

ATC

clonazepam; systemic

1.8

8.7

131

751

A10AA01, ,

ATC

2.3

8.6

265

PHD76

NOMESCO Finland

Resection of long saphenous vein

1.9

8.6

112

612

M79.1

ICD-10 Finland

Myalgia

1.4

8.6

342

2462

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

8.6

115

635

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.6

8.6

N17.8

ICD-10 Finland

Other acute renal failure

2.9

8.5

131

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

8.5

171

1060

C10AC01

ATC

colestyramine; oral

2.2

8.5

305

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

8.5

305

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

4.1

8.5

CK2S4, ,

SPAT

2.6

8.5

188

R01AD58

ATC

fluticasone, combinations; nasal

1.3

8.5

548

4283

ZX120, ,

SPAT

2.9

8.5

137

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

8.5

108

587

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

8.5

266

1829

E87.6

ICD-10 Finland

Hypokalaemia

2.0

8.5

460

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

8.5

523

4060

N01

ICPC

Headache

1.5

8.5

238

1599

CKC12

NOMESCO Finland

Photocoagulation of retina

1.9

8.4

102

545

WXQ20

NOMESCO Finland

UVA broad spectrum light therapy

90.3

8.4

WXQ26

NOMESCO Finland

UVB broad spectrum light therapy

90.3

8.4

S22.3

ICD-10 Finland

Fracture of rib

1.7

8.4

169

1049

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.9

8.4

106

575

N05AA02

ATC

levomepromazine; systemic

2.0

8.4

455

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

8.4

490

S01GX02

ATC

levocabastine; ophthalmic

1.8

8.4

121

685

H01.0

ICD-10 Finland

Blepharitis

1.7

8.3

148

888

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.8

8.3

111

612

J01FA10

ATC

azithromycin; systemic

1.3

8.3

1353

11931

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.9

8.3

106

576

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

8.3

133

775

J30.3

ICD-10 Finland

Other allergic rhinitis

2.1

8.3

361

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

10.8

8.3

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

8.3

203

1322

E66.0

ICD-10 Finland

Obesity due to excess calories

3.1

8.2

107

L13.9

ICD-10 Finland

Bullous disorder, unspecified

7.1

8.2

N02AA05

ATC

oxycodone; systemic

1.4

8.2

428

3232

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

8.2

1009

8599

A10AA02, ,

ATC

2.1

8.2

356

SPAT1325

SPAT

Vaccination

1.3

8.2

742

6081

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.3

8.2

SPAT1360

SPAT

Extensive global examination

1.7

8.2

150

908

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

8.2

466

SPF40

NOMESCO Finland

Removal and reattachment of crown or small bridge

2.6

8.2

180

R01AD12

ATC

fluticasone furoate; nasal

1.3

8.2

698

5677

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

7.5

8.1

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

8.1

279

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.6

8.1

I50.1

ICD-10 Finland

Left ventricular failure

1.8

8.1

109

603

UJD02

NOMESCO Finland

Gastroscopy

1.8

8.1

109

603

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

8.1

338

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.2

8.1

C07AB02

ATC

metoprolol; systemic

1.4

8.1

448

3418

207

Kela drug reimbursment

Chronic arrhythmias

1.4

8.0

358

2632

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

8.9

8.0

XCK00

NOMESCO Finland

Perimetry

1.7

8.0

134

791

R01AD11

ATC

triamcinolone; nasal

1.6

8.0

191

1236

R03AC12

ATC

salmeterol; inhalant

1.9

8.0

512

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.0

8.0

442

K08.80

ICD-10 Finland

Toothache NOS

1.6

8.0

202

1326

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.5

8.0

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

8.0

127

740

A07AA02

ATC

nystatin; oral

1.8

8.0

127

740

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

8.0

144

869

B01AC04

ATC

clopidogrel; oral

1.4

8.0

369

2732

A07EA06

ATC

budesonide; oral, local oral

2.0

8.0

422

WX320

NOMESCO Finland

Spinalanesthesy

1.3

8.0

576

4575

S10

ICPC

Boil/carbuncle

1.7

7.9

138

825

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

7.9

184

1185

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

7.9

102

558

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.6

7.9

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.0

7.9

403

WX892

NOMESCO Finland

Monitored bed care

1.6

7.9

173

1098

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

7.8

7.9

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

7.9

111

624

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.5

7.8

196

QXA70, ,

SPAT

2.8

7.8

138

H57.1

ICD-10 Finland

Ocular pain

1.9

7.8

481

A05

ICPC

Feeling ill

1.7

7.8

127

745

A10BK01

ATC

dapagliflozin; oral

1.6

7.8

186

1205

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

7.8

344

WZA00

NOMESCO Finland

Concise certificate

1.7

7.8

149

914

L16

ICPC

Ankle symptom/complaint

1.5

7.8

275

1938

K03.66

ICD-10 Finland

Tooth plaque

1.6

7.7

178

1142

SFA00

NOMESCO Finland

Small restoration

1.4

7.7

322

2338

WX882

NOMESCO Finland

High dependency care

2.2

7.7

311

D05AX03

ATC

calcitriol; topical

3.0

7.7

106

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.0

7.7

106

C08CA02

ATC

felodipine; oral

1.5

7.7

208

1384

L41.1

ICD-10 Finland

Pityriasis lichenoides chronica

45.1

7.7

R03AC13

ATC

formoterol; inhalant

1.8

7.7

111

628

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

7.7

424

3231

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

7.7

163

1026

R52.1

ICD-10 Finland

Chronic intractable pain

3.4

7.7

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

7.6

618

4983

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

7.6

157

981

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.0

7.6

B01AF02

ATC

apixaban; oral

1.4

7.6

311

2252

R4180

NOMESCO Finland

Podiatric therapy

2.8

7.6

129

Z08

ICPC

Social welfare problem

2.8

7.6

129

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.2

7.6

268

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

7.6

152

943

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.6

7.6

R09

ICPC

Sinus symptom/complaint

1.6

7.6

184

1197

N03AX09

ATC

lamotrigine; oral

1.9

7.5

530

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

4.1

7.5

RJ410, ,

NOMESCO Finland

6.2

7.5

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.0

7.5

417

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

3.0

7.5

108

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

7.5

121

708

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.1

7.5

322

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

7.5

104

582

134

Kela drug reimbursment

General erythroderma

7.1

7.5

EKA10

NOMESCO Finland

iopsy of buccal mucosa

2.3

7.4

251

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.2

7.4

264

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.8

7.4

111

636

J01DA06

ATC

[U] cefuroxime

1.4

7.4

310

2254

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

7.4

378

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

7.4

179

1164

A01AB04

ATC

amphotericin B; local oral

1.8

7.3

549

ULA02

NOMESCO Finland

Kolposcopy

1.6

7.3

183

1198

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

8.4

7.3

M07.3

ICD-10 Finland

Other psoriatic arthropathies

3.1

7.3

69240

ICD-8 Finland

Other eczema and dermatitis, Due to other chemicals

+∞

7.3

SDA03

NOMESCO Finland

Periodontal treatment

1.3

7.3

943

8059

T74.1

ICD-10 Finland

Physical abuse

2.6

7.3

161

WVA20, ,

SPAT

1.9

7.3

486

L86

ICPC

Back syndrome with radiating pain

1.6

7.3

145

899

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

3.2

7.3

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

1.9

7.3

479

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

7.3

601

4857

C09AA05

ATC

ramipril; oral

1.3

7.2

567

4549

P03

ICPC

Feeling depressed

1.5

7.2

200

1340

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.9

7.2

116

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

7.2

137

839

E87.5

ICD-10 Finland

Hyperkalaemia

2.4

7.2

192

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

7.3

7.2

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.7

7.2

139

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

7.1

105

598

W17

ICD-10 Finland

Other fall from one level to another

1.9

7.1

503

L27.2

ICD-10 Finland

Dermatitis due to ingested food

30.1

7.1

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.9

7.1

482

D69.2

ICD-10 Finland

Other nonthrombocytopenic purpura

6.6

7.1

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.1

7.1

329

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

7.1

625

5091

S16

ICPC

Bruise/contusion

2.0

7.1

350

E66

ICD-10 Finland

Obesity

1.7

7.0

121

721

L01

ICPC

Neck symptom/complaint

1.4

7.0

369

2787

M10.0

ICD-10 Finland

Idiopathic gout

1.9

7.0

420

J01CF02

ATC

cloxacillin; systemic

2.3

7.0

219

R03BA08

ATC

ciclesonide; inhalant

1.5

7.0

186

1234

SPAT1104

SPAT

Monitoring of emergency patient

1.6

7.0

141

876

R07.3

ICD-10 Finland

Other chest pain

1.5

7.0

236

1647

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

7.0

145

908

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.0

7.0

338

SPAT1058

SPAT

PEF monitoring instruction

1.6

7.0

176

1155

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

7.0

309

2269

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.0

7.0

102

RS222, ,

NOMESCO Finland

3.0

7.0

102

JF1BD

NOMESCO Finland

Very extensive small bowel CT

4.4

7.0

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.4

7.0

195

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.6

6.9

147

C07AG02

ATC

carvedilol; oral

1.7

6.9

128

778

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.2

6.9

246

K65.0

ICD-10 Finland

Acute peritonitis

3.0

6.9

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.7

6.9

TK820

NOMESCO Finland

Peritoneal dialysis

5.5

6.9

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.9

6.9

480

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.1

6.9

279

F61.0

ICD-10 Finland

Mixed personality disorders

2.7

6.9

136

C09CA06

ATC

candesartan; oral

1.3

6.9

566

4566

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

1.7

6.9

127

772

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

6.9

113

666

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

6.8

474

P76

ICPC

Depressive disorder

1.6

6.8

140

874

C10AA01

ATC

simvastatin; oral

1.2

6.8

954

8209

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

6.8

460

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.7

6.8

122

735

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

6.8

816

6897

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

3.4

6.8

A07EC02

ATC

mesalazine; oral, rectal

1.7

6.8

115

682

D51.0

ICD-10 Finland

Vitamin B12deficiency anaemia due to intrinsic factor deficiency

4.1

6.8

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

6.8

167

1089

R08

ICPC

Nose symptom/complaint other

1.9

6.8

432

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.8

6.8

S17

ICPC

Abrasion/scratch/blister

2.2

6.8

235

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

6.8

669

5523

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

11.0

6.8

S01GX05

ATC

lodoxamide; ophthalmic

2.9

6.8

109

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.5

6.8

173

J20

ICD-10 Finland

Acute bronchitis

1.5

6.8

224

1558

WQ066, ,

NOMESCO Finland

40.2

6.8

I50

ICD-10 Finland

Heart failure

2.1

6.8

315

N02AC04

ATC

dextropropoxyphene; oral

1.9

6.8

412

L73.9

ICD-10 Finland

Follicular disorder, unspecified

5.7

6.7

TPH04, ,

SPAT

2.9

6.7

104

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

6.7

249

1769

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.5

6.7

N03AF01

ATC

carbamazepine; oral, rectal

1.7

6.7

107

625

U04

ICPC

Incontinence urine

1.6

6.7

133

824

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.2

6.7

243

RJ414, ,

NOMESCO Finland

7.2

6.7

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.2

6.7

263

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

6.7

120

725

ZXC10

NOMESCO Finland

Use of laser

2.2

6.6

244

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.2

6.6

244

M01AC06

ATC

meloxicam; systemic, rectal

1.3

6.6

838

7124

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.5

6.6

151

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.1

6.6

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

6.6

367

2799

P20

ICPC

Memory disturbance

1.4

6.6

318

2370

M02AA07

ATC

piroxicam; topical

1.3

6.6

819

6952

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

6.6

348

2633

D01AA02

ATC

natamycin; topical

2.2

6.5

226

C09CA03

ATC

valsartan; oral

1.5

6.5

212

1468

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

2.2

6.5

246

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

6.5

396

S20.2

ICD-10 Finland

Contusion of thorax

1.7

6.5

122

745

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.0

6.5

368

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.7

6.5

116

700

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

6.4

108

640

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

2.7

6.4

118

N06AX03

ATC

mianserin; oral

1.7

6.4

106

625

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.9

6.4

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.6

6.4

163

1072

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.9

6.4

384

SPAT1139

SPAT

Nutrition survey

1.9

6.4

377

A10AA03, ,

ATC

3.3

6.4

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

6.4

364

2784

N07BB01

ATC

disulfiram; oral

1.8

6.4

485

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

6.4

131

819

N06AG02

ATC

moclobemide; oral

1.8

6.4

522

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

3.0

6.4

S72

ICPC

Scabies/other acariasis

2.6

6.4

136

SPD01

NOMESCO Finland

Mucosa-supported complete denture

2.9

6.4

102

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

6.4

275

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

6.4

302

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

2.5

6.4

160

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

6.4

107

635

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

4.1

6.4

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

6.3

471

3744

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

6.3

218

1528

C05AA08

ATC

fluocortolone; rectal, topical

1.4

6.3

297

2202

L12.9

ICD-10 Finland

Pemphigoid, unspecified

8.2

6.3

WX704

NOMESCO Finland

Intubation

1.5

6.3

185

1255

S11

ICPC

Skin infection post-traumatic

2.8

6.3

108

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.8

6.3

561

XF600, ,

SPAT

1.8

6.3

524

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

6.3

422

QXA05

NOMESCO Finland

Skin division, unspecified location

6.0

6.3

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

6.3

223

1572

M86.8

ICD-10 Finland

Other osteomyelitis

11.0

6.3

8070/3-C44.7

ICD-O-3

Squamous cell carcinoma, NOS, of skin of lower limb and hip

11.0

6.3

R55

ICD-10 Finland

Syncope and collapse

1.4

6.3

236

1682

A07AA09

ATC

vancomycin; oral

2.6

6.3

137

J01MA06

ATC

norfloxacin; oral

1.4

6.3

283

2084

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

6.3

222

1565

L29.3

ICD-10 Finland

Anogenital pruritus, unspecified

18.1

6.3

B01AA03

ATC

warfarin; systemic

1.3

6.3

397

3086

T82

ICPC

Obesity

1.8

6.2

496

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

6.2

332

2513

XX9XT

NOMESCO Finland

Other radiological intervention

26.7

6.2

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

6.2

846

7242

M54.6

ICD-10 Finland

Pain in thoracic spine

1.5

6.2

162

1072

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.6

6.2

132

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.6

6.2

132

J05AB11

ATC

valaciclovir; oral

1.4

6.2

311

2331

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.9

6.2

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

6.2

904

7797

Z50.1

ICD-10 Finland

Other physical therapy

1.7

6.2

118

724

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.4

6.2

162

P06

ICPC

Sleep disturbance

1.4

6.2

282

2081

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.0

6.2

347

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

6.2

101

595

RS211, ,

NOMESCO Finland

6.3

6.2

Z01.7

ICD-10 Finland

Laboratory examination

1.3

6.2

379

2933

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

6.1

255

1851

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

6.1

203

1412

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.5

6.1

162

1075

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.3

6.1

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

6.1

558

4555

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

2.4

6.1

169

K05.30

ICD-10 Finland

Periodontitis complex

1.4

6.1

344

2626

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

6.1

187

1281

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

2.8

6.1

K30

ICD-10 Finland

Functional dyspepsia

1.4

6.1

245

1770

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

6.1

285

2114

S01AD03

ATC

aciclovir; ophthalmic

1.9

6.1

399

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.1

6.1

267

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

6.1

157

1038

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.8

6.1

105

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.6

6.0

122

760

D06BB04

ATC

podophyllotoxin; topical

1.8

6.0

531

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

6.0

378

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.6

6.0

134

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.9

6.0

414

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

6.7

6.0

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

6.0

239

1721

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.8

6.0

436

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

306

53.74

307.65

1.5

1.4

16.00

25.14

u/ml

0.69

(40768443) Skin Pathology biopsy report

553

759

8.89

307.65

1.4

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

268

53.94

307.65

1.4

607.14

293.33

titre

—

(3005322) IgE [Units/volume] in Serum or Plasma

514

1346

4.47

180.22

1.6

1.3

752.89

154.66

u/ml

4.58

487

1242

(3006315) Basophils [#/volume] in Blood

1813

12046

2.51

109.22

9.5

6.2

0.04

e9/l

5.20

1658

10236

(3001604) Monocytes [#/volume] in Blood

1808

12011

2.50

108.74

9.6

6.2

0.61

0.58

e9/l

4.53

1653

10215

(3013115) Eosinophils [#/volume] in Blood

1841

12460

2.48

104.15

9.8

6.4

0.24

0.19

e9/l

20.70

1695

10772

(3019198) Lymphocytes [#/volume] in Blood

1823

12294

2.46

103.80

9.7

6.2

1.80

1.92

e9/l

2.91

1680

10738

(3007853) Bacteria identified in Skin by Aerobe culture

625

2649

2.76

97.69

2.2

1.7

—

(3019069) Monocytes/Leukocytes in Blood

1649

11087

2.24

87.84

10.0

6.5

8.84

8.86

0.07

1596

10380

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

978

5330

2.30

87.55

1.5

1.3

2.03

1.60

u/ml

0.47

251

1422

(3006504) Eosinophils/Leukocytes in Blood

1642

11069

2.22

86.22

10.0

6.4

3.35

2.78

14.91

1589

10359

(3018010) Neutrophils/Leukocytes in Blood

1644

11123

2.21

85.05

9.7

6.3

58.41

57.33

3.55

1608

10616

(3022096) Basophils/Leukocytes in Blood

1637

11078

2.20

84.35

10.1

6.5

0.70

0.67

1.23

1584

10355

(3013650) Neutrophils [#/volume] in Blood by Automated count

1892

13597

2.28

83.51

12.4

9.6

4.30

4.10

e9/l

3.42

1720

11714

(3007164) IgA [Mass/volume] in Serum or Plasma

876

4642

2.31

82.98

1.7

1.5

2.72

2.45

g/l

2.49

526

2878

(3002030) Lymphocytes/Leukocytes in Blood

1660

11353

2.18

82.47

10.0

6.4

25.89

27.73

10.76

1614

10751

(3023368) Bacteria identified in Blood by Culture

1104

6621

2.12

75.16

6.3

4.3

—

(3000494) Fungus identified in Specimen by Culture

580

2741

2.42

69.92

1.8

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1556

10910

1.99

65.71

6.6

5.0

35.21

35.68

g/l

2.69

1480

10259

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1023

6331

1.99

60.65

2.9

2.3

2.84

2.82

mg/l

0.10

908

5456

(3037522) Nuclear Ab [Titer] in Serum

629

3265

2.20

59.76

1.6

1.3

477.03

532.34

titre

0.31

148

700

(3020779) Urea [Moles/volume] in Serum or Plasma

473

2181

2.41

59.39

11.3

7.3

11.19

9.84

mmol/l

3.31

450

2088

(3042936) Bacteria identified in Isolate by Culture

643

3387

2.18

58.76

2.5

2.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

449

2036

2.44

58.44

2.4

2.9

66.90

66.31

g/l

0.91

418

1868

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2178

17623

2.18

57.11

6.2

4.3

15.29

12.13

mm/h

16.81

2095

16480

(3022948) Iron [Moles/volume] in Serum or Plasma

738

4152

2.07

56.42

3.8

2.6

12.12

13.15

umol/l

3.58

692

3877

(3004789) Transferrin [Mass/volume] in Serum or Plasma

691

3864

2.06

53.27

3.8

2.5

2.31

2.32

g/l

0.03

640

3582

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1700

12778

1.88

52.92

7.2

6.6

11.30

11.55

umol/l

0.23

1641

12205

(3003458) Phosphate [Moles/volume] in Serum or Plasma

602

3224

2.11

51.95

10.6

5.8

1.10

1.04

mmol/l

5.17

569

2986

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2228

18419

2.16

51.64

11.0

8.2

81.83

79.43

u/l

1.67

2153

17486

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1147

7678

1.85

51.30

3.5

2.6

57.57

70.52

u/l

0.65

1075

7107

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

644

3575

2.05

50.26

4.0

2.6

21.11

22.86

2.77

598

3336

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

256

1000

2.72

44.86

1.9

2.6

3.74

3.63

g/l

0.72

236

912

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

256

1001

2.72

44.77

1.9

2.6

7.48

7.37

g/l

0.46

236

912

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

256

1001

2.72

44.77

1.9

2.6

4.29

4.20

g/l

0.81

236

912

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1495

11134

1.76

44.43

4.3

3.0

118.81

128.79

ug/l

0.94

1399

10391

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

229

861

2.81

43.14

1.9

2.7

10.22

g/l

0.00

208

768

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1612

12332

1.75

42.94

11.6

7.2

1.21

mmol/l

2.42

1415

10656

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

242

940

2.73

42.82

1.9

2.7

2.85

2.94

g/l

0.74

222

852

(3013826) Glucose [Moles/volume] in Serum or Plasma

1803

14268

1.78

42.40

7.4

5.0

7.04

6.72

mmol/l

6.75

1727

13558

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1474

11060

1.73

41.47

10.2

6.5

1.21

mmol/l

1.89

1380

10202

(3036481) Cortisol [Moles/volume] in Serum or Plasma

434

2244

2.11

40.14

2.4

2.2

358.56

381.36

nmol/l

1.51

405

2078

(3012516) Albumin [Mass/volume] in Urine

1142

8041

1.72

40.04

4.2

3.5

74.24

43.77

mg/l

2.40

779

5054

(3012095) Magnesium [Moles/volume] in Serum or Plasma

681

4121

1.87

40.01

3.8

3.4

0.80

0.82

mmol/l

3.52

644

3893

(3027945) Reticulocytes/Erythrocytes in Blood

507

2781

2.01

39.91

2.6

2.7

1.82

1.81

0.09

461

2490

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1461

11029

1.70

39.36

3.0

2.4

74.44

77.99

nmol/l

5.23

1346

9992

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

180

625

3.01

39.14

1.5

1.7

0.24

g/l

0.24

169

598

(3020682) Albumin/Creatinine [Ratio] in Urine

1153

8176

1.71

39.13

5.0

4.1

13.99

7.90

mg/mmol

1.89

781

5026

(3009508) Creatinine [Moles/volume] in Urine

1185

8467

1.71

39.09

4.1

3.4

7.04

7.52

mmol/l

3.67

1022

7165

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

183

642

2.98

39.07

1.5

1.7

1.23

1.19

g/l

0.93

173

613

(3017143) Hepatitis C virus Ab [Presence] in Serum

477

2579

2.03

39.02

2.0

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

192

693

2.90

38.95

1.9

2.6

0.00

g/l

-0.00

169

614

(3018418) pH of Serum or Plasma

1067

7427

1.72

38.63

7.1

4.2

7.39

7.40

1.35

818

5356

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1083

7572

1.71

38.55

2.6

2.2

209.56

220.46

u/l

0.13

1021

7170

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

669

4067

1.86

38.53

2.3

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1016

6984

1.73

38.45

1.9

1.7

20.10

20.47

nmol/l

0.33

882

5909

(3000850) Epithelial cells [#/volume] in Urine

831

5397

1.78

38.43

3.8

2.7

5.78

5.59

e6/l

0.14

761

4909

(3026008) Bacteria identified in Urine by Culture

1062

7397

1.71

38.26

3.9

3.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

220

864

2.68

38.01

2.1

2.6

0.50

1.09

g/l

2.32

192

742

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1429

10798

1.68

37.70

2.5

2.1

94.04

96.22

pmol/l

1.01

821

5643

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

195

723

2.83

37.62

1.9

2.6

0.01

0.02

g/l

0.29

175

655

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

181

651

2.91

36.93

1.9

2.7

0.00

g/l

-0.00

169

614

(40760892) CBC W Ordered Manual Differential panel - Blood

804

5223

1.77

36.86

6.3

4.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

624

3759

1.86

36.77

2.2

1.8

—

(3032080) INR in Blood by Coagulation assay

1468

11226

1.67

36.52

18.0

15.2

1.26

1.25

inr

0.03

1252

9348

(36660697) Celiac disease serology panel - Serum

366

1834

2.15

36.51

1.3

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

249

1066

2.47

35.96

1.2

1.1

335.00

113.93

titre

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1042

7323

1.69

35.63

3.7

3.2

2243.64

1299.45

ng/l

2.64

916

6303

(3023520) Reticulocytes [#/volume] in Blood

408

2156

2.05

35.29

2.5

2.7

69.47

69.58

e9/l

0.02

314

1574

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

373

1907

2.11

35.25

5.6

3.8

115.46

87.90

ng/l

4.12

329

1649

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

345

1716

2.16

35.00

1.8

1.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1890

15535

1.71

34.84

6.5

4.6

2726.39

1720.00

e6/l

0.24

221

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

498

2840

1.92

34.55

3.4

4.4

237.85

246.74

u/l

0.70

478

2693

(3021601) Nitrite [Presence] in Urine by Test strip

1597

12585

1.65

34.42

5.2

3.8

0.00

estimate

0.80

376

2626

(3012544) pH of Venous blood

457

2536

1.96

34.36

6.1

3.7

7.37

7.38

1.57

288

1430

(3037467) Urinalysis macro (dipstick) panel - Urine

1954

16233

1.72

34.34

6.4

4.5

—

2.96

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

703

4477

1.77

34.09

1.4

1.3

31.72

32.99

iu/ml

0.10

210

1399

(3035350) Ketones [Presence] in Urine by Test strip

1610

12747

1.64

33.75

5.2

3.9

3.40

2.88

estimate

0.05

382

2695

(3026493) Urate [Moles/volume] in Serum or Plasma

916

6292

1.69

33.70

3.5

2.7

356.00

340.42

umol/l

4.22

811

5576

(3009261) Glucose [Presence] in Urine by Test strip

1617

12834

1.64

33.40

5.2

3.9

2.90

0.13

estimate

0.48

350

2524

(3019309) Folate [Moles/volume] in Red Blood Cells

641

3998

1.79

33.26

1.9

1.7

1193.48

1166.22

nmol/l

0.30

510

3041

(3021589) Normoblasts [#/volume] in Blood

1381

10606

1.61

32.08

17.4

11.2

0.00

e9/l

2.16

1182

8627

(3023420) DNA double strand Ab [Units/volume] in Serum

216

915

2.48

31.83

1.6

1.8

6.76

7.51

iu/ml

0.11

227

(3021447) Carbon dioxide [Partial pressure] in Venous blood

444

2508

1.92

31.46

6.1

3.7

5.87

5.83

kpa

0.35

436

2430

(3015171) Extractable nuclear Ab [Units/volume] in Serum

206

859

2.51

31.39

1.3

1.2

2.09

0.83

u/ml

0.28

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

7.79

31.05

1.9

1.4

8.85

8.86

ug/l

0.00

(3015736) pH of Urine

1322

10116

1.60

30.66

4.2

3.4

6.32

6.23

1.98

733

5689

(3002582) Erythrocytes [#/volume] in Urine

1080

7875

1.62

30.66

4.7

3.3

75.81

88.92

e6/l

0.13

886

5963

(3002032) Base excess in Venous blood by calculation

431

2438

1.91

30.33

6.7

3.7

1.45

1.89

mmol/l

1.56

384

2107

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

487

2869

1.85

30.18

2.2

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

652

4190

1.73

30.07

1.4

1.3

11.58

11.57

u/ml

0.00

255

1648

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

182

730

2.60

30.05

1.7

1.5

0.28

9.08

iu/ml

0.48

134

(3005719) IgG [Mass/volume] in Serum or Plasma

347

1833

2.02

29.76

2.9

2.8

10.74

10.69

g/l

0.06

314

1692

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

474

2799

1.84

29.06

2.6

2.8

6.84

8.00

umol/l

0.84

410

2474

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

536

3286

1.79

29.02

2.0

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1142

8544

1.58

28.46

3.7

3.5

2.35

2.36

mmol/l

1.09

1050

7791

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2122

18363

1.71

28.44

5.3

4.4

14.81

14.79

pmol/l

0.09

1997

16877

(3026782) Osmolality of Urine

692

4598

1.68

27.90

4.0

2.9

509.79

532.52

mosm/kgh2o

2.07

620

4023

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

501

3049

1.79

27.68

2.2

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

398

2263

1.89

27.38

9.9

7.8

1.34

mmol/l

0.01

392

2220

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

242

1150

2.21

27.30

1.2

1.1

2.54

1.72

u/ml

—

(3018095) Leukocytes [#/volume] in Urine

1183

9021

1.55

26.51

5.6

3.9

104.92

97.06

e6/l

0.10

908

6290

(3012494) Peanut IgE Ab [Units/volume] in Serum

8.78

26.30

1.0

1.1

3.88

0.22

u/ml

0.59

(40758558) Short blood count panel - Blood

1000

7357

1.57

26.21

7.6

6.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

191

836

2.38

26.13

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

281

1444

2.05

25.85

2.0

1.9

1.23

1.31

g/l

0.29

254

1331

(3034274) Bile acid [Moles/volume] in Serum --fasting

182

4.04

25.58

1.8

2.0

11.04

6.14

umol/l

1.18

123

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

717

4917

1.62

25.10

2.7

3.0

2.45

mmol/l

0.11

644

4437

(3002179) Metamyelocytes/Leukocytes in Blood

364

2068

1.88

24.97

4.8

4.1

0.52

0.72

1.50

137

614

(3017181) Myelocytes/Leukocytes in Blood

379

2182

1.86

24.93

5.1

4.3

0.68

0.90

1.03

141

651

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2513

23116

2.13

24.85

26.8

15.7

24.65

24.35

mg/l

0.18

2238

19025

(3030467) Casts [#/volume] in Urine by Automated count

928

6801

1.55

24.29

4.5

3.2

0.43

0.45

e6/l

0.10

734

4957

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

758

5321

1.59

23.87

1.9

1.8

1.30

1.28

mg/l

0.05

617

4144

(3021440) Promyelocytes/Leukocytes in Blood

362

2082

1.85

23.83

5.2

4.4

0.06

0.12

1.21

124

552

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

213

1016

2.19

23.75

1.9

2.0

39.41

39.42

u/l

0.00

184

910

(3003888) Timothy IgE Ab [Units/volume] in Serum

331

3.07

22.98

1.1

4.96

4.16

u/ml

0.15

169

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

411

2486

1.77

22.84

4.8

3.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

141

575

2.53

22.48

1.1

8.78

5.78

eliau/ml

0.22

(3000991) Gas panel - Venous blood

368

2166

1.81

22.40

12.7

9.1

—

(36304419) Bacteria [Presence] in Urine

883

6490

1.53

22.39

4.4

3.1

0.00

estimate

—

(3048689) Calprotectin [Mass/mass] in Stool

471

2976

1.70

22.37

2.5

2.4

135.67

134.60

ug/g

0.03

388

2395

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

333

1904

1.85

22.27

3.1

2.9

212.53

190.10

ng/l

0.34

306

1732

(3024354) Oxygen [Partial pressure] in Venous blood

357

2093

1.81

22.00

5.2

3.1

4.64

4.52

kpa

0.44

351

2027

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2378

21643

1.78

21.86

6.7

5.4

1.86

1.93

mu/l

1.83

2268

20040

(3025159) Blasts/Leukocytes in Blood

358

2106

1.81

21.80

5.4

4.6

0.21

0.10

0.28

114

532

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

144

605

2.46

21.55

1.8

2.1

12.12

11.44

mg/l

0.36

135

558

(3019977) pH of Arterial blood

458

2909

1.69

21.24

9.4

7.9

7.41

7.42

0.66

239

1590

(3008401) Mugwort IgE Ab [Units/volume] in Serum

325

2.99

21.21

1.1

0.61

1.08

u/ml

0.55

131

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

457

2913

1.68

20.89

9.2

7.8

5.10

5.11

kpa

0.03

438

2803

(3027801) Oxygen [Partial pressure] in Arterial blood

457

2913

1.68

20.89

9.2

7.8

11.59

12.42

kpa

2.60

436

2802

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

118

459

2.64

20.73

1.8

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

120

472

2.61

20.61

1.8

1.4

31.82

18.91

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

101

4.72

20.56

1.1

1.0

0.45

1.00

u/ml

0.34

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

147

637

2.38

20.56

2.1

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1200

9513

1.47

20.51

5.1

3.8

0.04

0.32

estimate

0.64

310

2146

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1165

9209

1.46

20.07

4.8

3.7

43.70

110.26

ng/l

0.74

844

6488

(3003396) Base excess in Arterial blood by calculation

451

2896

1.67

19.97

9.2

7.7

0.81

0.96

mmol/l

0.31

365

2376

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

200

999

2.08

19.77

1.9

2.09

2.17

ug/l

0.04

179

892

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

676

4798

1.54

19.65

4.6

3.8

397.87

453.51

ng/l

0.15

524

3759

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

124

511

2.49

19.35

1.3

1.2

1.08

4.07

u/ml

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

792

5831

1.51

19.34

4.6

3.7

0.25

0.15

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

106

405

2.68

19.30

1.1

3.16

1.61

u/ml

0.45

217

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1056

8239

1.46

19.23

3.9

3.2

31.79

35.03

u/l

0.79

986

7763

(3019550) Sodium [Moles/volume] in Serum or Plasma

2536

23720

2.01

19.01

30.4

18.6

139.31

139.74

mmol/l

14.12

2507

23275

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

109

427

2.62

18.89

1.9

1.4

157.82

153.72

au/ml

0.11

125

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

159

740

2.22

18.82

4.2

3.1

1.80

1.55

mg/l

2.37

150

676

(3023103) Potassium [Moles/volume] in Serum or Plasma

2538

23771

2.00

18.55

30.8

18.8

3.99

3.97

mmol/l

3.87

2508

23284

(3004119) Hemoglobin [Mass/volume] in Venous blood

278

1596

1.83

18.22

5.2

3.0

123.19

129.60

g/l

4.80

273

1545

(3023183) Ammonium ion [Moles/volume] in Plasma

122

514

2.44

18.17

2.8

2.9

29.50

36.51

umol/l

2.10

107

464

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

243

1339

1.89

18.13

5.2

2.8

0.61

0.62

0.12

243

1333

(3016502) Oxygen saturation in Arterial blood

405

2592

1.66

18.04

9.6

8.1

94.92

95.60

1.30

389

2502

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

146

669

2.25

17.95

1.3

1.2

23.24

42.43

u/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

119

499

2.45

17.91

2.0

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

117

492

2.44

17.50

9.6

5.8

285.76

687.88

iu/ml

0.76

(3018677) aPTT in Platelet poor plasma by Coagulation assay

541

3740

1.56

17.44

2.2

2.1

29.61

29.65

0.05

528

3649

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

243

1356

1.87

17.42

5.2

2.8

1.34

1.20

1.09

243

1351

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

168

825

2.10

17.36

2.8

2.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2390

22067

1.68

17.23

8.5

6.4

41.35

39.36

mmol/mol

16.66

2273

20668

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

383

2.62

17.09

3.9

2.9

19256.71

1660.28

u/ml

—

(3029937) Albumin [Presence] in Urine by Test strip

911

7030

1.44

17.05

5.7

4.0

0.00

estimate

1.54

346

2434

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

208

1112

1.94

16.98

1.7

1.8

1.65

1.53

g/l

1.06

177

968

(3021879) Hepatitis B virus core Ab [Presence] in Serum

290

1728

1.76

16.73

1.6

1.5

—

(40768797) Stomach Pathology biopsy report

493

3368

1.57

16.68

1.3

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

376

2407

1.65

16.65

2.5

2.2

0.20

0.21

g/l

0.85

347

2257

(3003327) Ova and parasites identified in Stool by Light microscopy

154

747

2.13

16.44

2.0

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

147

701

2.16

16.39

1.4

1.3

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

298

1810

1.73

16.05

1.5

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

303

2.76

15.97

1.1

1.28

0.66

u/ml

0.70

143

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

165

832

2.05

15.90

2.8

4.0

41.81

69.65

mg/l

0.80

135

718

(3042733) HLA Ab [Presence] in Serum

4.72

15.88

6.2

5.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

165

833

2.04

15.84

2.8

4.0

53.80

59.43

mg/l

0.22

134

721

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

100

410

2.49

15.82

1.3

96.00

541.67

titre

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

687

5101

1.46

15.48

1.8

1.7

14261625.26

32127342.91

pmol/l

0.56

582

4255

(40768446) Kidney Pathology biopsy report

4.33

15.47

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1350

11305

1.39

15.26

3.3

2.8

—

estimate

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

372

2433

1.61

15.04

10.4

8.5

118.74

121.84

g/l

2.13

362

2373

(3019150) Specific gravity of Urine by Refractometry

741

5609

1.44

15.00

5.0

4.0

1.02

kg/l

1.50

540

3764

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1810

15939

1.40

14.97

4.2

3.3

54.56

49.29

u/l

1.78

1712

14981

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

132

626

2.17

14.94

1.3

1.2

3.27

7.29

u/ml

0.37

(3014599) Egg white IgE Ab [Units/volume] in Serum

4.13

14.91

1.1

1.0

0.77

0.49

u/ml

0.55

(3034770) Mitochondria Ab [Titer] in Serum

144

708

2.09

14.85

1.2

680.00

1274.12

titre

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

238

2.90

14.66

1.2

50.71

63.77

u/l

1.42

210

(3025941) Bacteria identified in Stool by Culture

217

1233

1.83

14.66

1.4

1.2

—

(3017732) Neutrophils [#/volume] in Blood

442

3027

1.55

14.63

3.1

3.3

5.42

4.64

e9/l

0.57

394

2634

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

131

628

2.14

14.43

1.4

1.3

2.97

6.91

u/ml

1.01

100

(40767503) Oxygen content in Capillary blood by calculation

111

500

2.27

14.26

3.7

2.5

16.02

16.43

0.74

111

490

(3037756) Immunofixation for Serum or Plasma

110

494

2.28

14.23

1.5

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

120

561

2.19

14.09

1.5

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2405

22462

1.61

13.89

6.3

5.1

6.17

5.95

mmol/l

8.96

2250

20641

(3000475) Leukocytes [#/volume] in Synovial fluid

126

608

2.12

13.66

1.9

1.6

12292.01

13016.29

e6/l

0.09

429

(3030981) Hyaline casts [#/volume] in Urine by Automated count

308

1970

1.64

13.57

3.1

2.5

0.31

0.49

e6/l

1.06

298

1886

(3022145) Colonoscopy Study observation

401

2730

1.55

13.57

1.4

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

105

472

2.27

13.56

1.5

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

4.13

13.47

35.0

24.9

94.00

122.25

ug/l

1.76

(3014051) Protein [Presence] in Urine by Test strip

863

6815

1.39

13.44

3.5

2.9

0.00

0.02

0.74

164

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

139

3.42

13.43

1.6

1.5

6.37

6.59

u/l

0.04

116

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

130

640

2.08

13.38

1.8

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

224

2.86

13.23

1.2

1.4

7.79

6.81

g/l

0.96

164

(3019420) Tryptase [Mass/volume] in Serum or Plasma

3.98

13.16

1.3

1.8

10.98

11.64

ug/l

0.06

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

240

1451

1.72

13.09

11.2

10.3

15.51

16.03

2.13

231

1394

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.04

13.09

1.3

1.1

—

(3024471) HLA-A [Type]

4.42

13.08

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

106

486

2.23

13.07

1.3

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

312

2.54

13.05

1.7

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

578

4277

1.45

12.95

3.5

2.9

0.78

1.18

e6/l

2.40

315

2252

(3052851) Hemolysis interference index of Serum or Plasma

136

692

2.02

12.81

3.1

3.2

1.82

2.19

index

0.33

354

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

142

734

1.99

12.80

2.6

3.8

1.37

3.95

ratio

2.29

435

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

246

1510

1.69

12.69

11.1

9.9

24.19

24.30

mmol/l

0.21

240

1485

(3028192) IgG subclass 2 [Mass/volume] in Serum

224

2.81

12.66

1.2

1.4

2.91

2.98

g/l

0.12

166

(3024139) IgG subclass 3 [Mass/volume] in Serum

224

2.81

12.66

1.2

1.4

0.46

0.40

g/l

0.52

166

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

129

647

2.04

12.65

1.7

1.5

—

(1616796) Gas panel - Central venous blood

112

533

2.15

12.60

6.1

3.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

138

712

1.99

12.51

1.2

97.06

101.76

titre

0.07

(3024932) HLA-DR beta [Type]

4.34

12.40

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

383

2.34

12.28

1.3

1.6

1.00

0.78

g/l

0.81

302

(3019060) Gas panel - Arterial blood

237

1453

1.69

12.28

5.0

4.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

292

2.54

12.23

2.2

2.3

0.77

1.22

g/24h

1.48

163

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

298

2.52

12.23

1.1

5.13

2.98

eliau/ml

0.78

138

(3000570) Elastase.pancreatic [Mass/mass] in Stool

139

725

1.97

12.22

1.5

1.4

271.43

281.29

ug/g

0.22

426

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

137

714

1.97

12.07

1.4

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

849

6780

1.37

12.06

4.6

3.4

0.00

0.16

estimate

0.70

299

2053

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

125

632

2.02

12.00

1.6

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

160

881

1.87

11.96

2.1

2.3

554.34

444.30

ug/l

0.28

152

832

(3006184) Hemoglobin [Mass/volume] in Capillary blood

118

585

2.06

11.95

2.6

2.2

126.27

130.05

g/l

0.97

458

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

149

802

1.91

11.94

3.0

3.3

0.30

0.36

iu/ml

1.45

427

(3048929) Epstein Barr virus Ab [Presence] in Serum

130

668

1.99

11.93

1.4

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

389

2.30

11.86

1.3

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

435

2.23

11.78

1.6

1.2

279.62

270.46

u/ml

0.11

272

(40760888) Immunoglobulin light chains.free panel - Serum

112

548

2.09

11.75

3.2

4.2

—

(3033658) Prothrombin time (PT) actual/Normal

785

6219

1.37

11.65

5.5

4.1

90.79

89.70

0.60

763

6092

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2576

24653

1.84

11.63

33.3

20.6

85.26

77.14

umol/l

9.75

2560

24368

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

8.64

11.50

14.2

11.4

5.00

5.61

mmol/l

0.49

(3012501) Base excess in Blood by calculation

102

487

2.14

11.41

7.4

4.2

2.99

2.60

mmol/l

0.72

330

(3003181) Sodium [Moles/volume] in Urine

454

2.18

11.41

1.4

1.3

60.74

61.85

mmol/l

0.11

368

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

435

2.20

11.37

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

435

2.20

11.37

1.4

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2442

23072

1.57

11.32

6.1

5.1

4.56

4.65

mmol/l

4.28

2295

21623

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

251

1596

1.63

11.29

5.0

3.6

5.18

5.17

kpa

0.07

242

1534

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

288

1894

1.58

11.26

3.0

2.8

60.84

66.40

ml/min/173m2

1.54

141

789

(4062490) Immunoglobulin typing, IgG

222

2.69

11.19

1.2

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1597

14090

1.32

11.16

3.2

2.8

—

(3016038) Potassium [Moles/volume] in Urine

162

3.00

11.11

1.1

1.2

24.94

36.63

mmol/l

4.10

145

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2427

22924

1.54

10.98

5.8

5.1

1.41

1.47

mmol/l

11.17

2266

21347

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

202

1226

1.70

10.86

1.6

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

268

2.50

10.76

1.1

3.44

1.59

u/ml

0.84

118

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.44

10.73

1.5

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

413

2.19

10.71

1.8

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

105

522

2.05

10.59

1.6

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

216

1344

1.66

10.58

4.7

3.4

2.14

1.90

mmol/l

0.38

157

998

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

135

3.14

10.57

1.3

1.2

90.71

81.90

u/l

0.33

113

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

524

3938

1.41

10.54

3.7

3.1

2.70

2.53

e6/l

0.17

256

1905

(3014148) Varicella zoster virus Ab [Titer] in Serum

284

2.43

10.45

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

958

7920

1.32

10.45

2.9

2.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

268

1764

1.58

10.43

1.9

1.7

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

267

2.47

10.35

1.9

1.6

58.43

57.60

0.05

164

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

342

2382

1.50

10.27

3.3

2.4

32.34

60.04

u/l

0.76

292

2020

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

104

522

2.03

10.23

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.12

10.15

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

222

2.60

10.14

1.6

1.3

133487.51

113156.22

e6/l

0.06

149

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2462

23392

1.55

10.11

6.8

5.8

2.65

2.72

mmol/l

3.10

2309

21817

(3009343) pH of Capillary blood

240

1551

1.60

10.10

5.1

3.6

7.41

7.42

1.25

206

1287

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

465

2.08

10.00

7.3

3.1

13.47

9.27

pmol/l

1.94

465

(3015235) Bicarbonate [Moles/volume] in Capillary blood

151

871

1.78

9.74

4.1

2.8

24.35

24.93

mmol/l

1.01

151

856

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2092

19344

1.35

9.71

31.6

19.5

13.91

13.64

15.10

2077

19078

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2326

21895

1.43

9.58

5.1

4.3

1.41

1.29

mmol/l

10.56

2165

20176

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

297

2038

1.51

9.57

2.5

2.3

6.47

7.59

ug/l

0.35

267

1814

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

232

1513

1.58

9.39

2.0

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

746

6026

1.33

9.36

3.0

2.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

286

1956

1.52

9.36

6.6

3.7

1.22

1.23

mmol/l

2.46

253

1681

(3004616) Nuclear Ab [Presence] in Serum

275

2.36

9.28

1.4

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

251

2.42

9.23

1.1

4.53

2.84

u/ml

0.38

100

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2547

24460

1.64

9.18

18.1

12.1

26.05

26.24

u/l

0.25

2502

23797

(3002079) Sodium [Moles/time] in 24 hour Urine

105

3.27

9.17

1.4

1.3

175.16

165.92

mmol/24h

0.20

105

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

240

2.45

9.13

1.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2371

22439

1.44

9.07

24.7

15.5

78.56

80.38

ml/min/173m2

3.53

2236

20829

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

104

546

1.94

9.05

1.5

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

112

605

1.89

8.95

4.1

3.0

8.12

8.15

kpa

0.08

112

590

(3037121) Protein [Mass/volume] in Urine

144

842

1.75

8.89

3.5

3.3

268.86

306.51

mg/l

0.26

360

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

508

1.96

8.85

3.9

1.9

0.93

0.84

nmol/l

0.68

431

(3002619) Bacteria identified in Specimen by Culture

4.50

8.83

1.3

1.1

—

(3017354) Segmented neutrophils/Leukocytes in Blood

244

2.41

8.82

2.7

3.3

56.96

59.01

0.31

211

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

134

2.94

8.81

1.3

1.2

15.50

20.86

u/l

0.49

110

(3035933) Granulocytes/Leukocytes in Blood

505

1.95

8.66

4.7

3.2

59.25

57.76

0.57

505

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

180

1128

1.64

8.60

5.1

4.9

1.68

1.59

0.53

169

1057

(3015076) Soybean IgE Ab [Units/volume] in Serum

3.36

8.48

1.1

1.0

0.28

0.13

u/ml

—

(3004809) Band form neutrophils/Leukocytes in Blood

387

2.07

8.36

3.2

3.5

1.18

1.65

0.57

343

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

238

2.38

8.35

1.1

1.0

0.22

0.07

u/ml

0.88

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

100

533

1.91

8.34

2.6

2.3

122.82

101.34

ug/min

0.11

331

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

9.46

8.27

1.0

1.17

0.21

u/ml

—

(40768804) Tissue Pathology biopsy report

1115

9623

1.27

8.17

2.2

2.1

—

(3028433) Virus identified in Specimen by Culture

3.92

8.15

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

228

1531

1.53

8.12

8.6

6.6

24.30

24.55

mmol/l

0.46

214

1459

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.40

8.07

1.4

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

505

1.91

8.00

1.3

1.2

45.61

41.64

u/ml

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

165

1033

1.64

7.93

5.3

5.1

0.85

0.88

0.51

155

965

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

303

2.17

7.83

1.6

—

(3011412) CD3 cells [#/volume] in Blood

186

2.50

7.66

2.0

2.1

1206.72

1096.15

e6/l

0.44

168

(3016650) Hepatitis A virus Ab [Presence] in Serum

409

1.98

7.56

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

147

906

1.66

7.52

2.5

1.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

489

3824

1.34

7.47

1.6

1.5

—

(3044927) Protein electrophoresis panel - Urine

257

2.24

7.46

1.2

1.1

—

(3012565) Volume of 24 hour Urine

114

2.92

7.43

2.1

2.6

1856.31

1870.55

0.03

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

7.66

7.38

1.1

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

13.39

7.38

5.7

3.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

115

2.89

7.32

1.1

1813.03

1428.26

miu/ml

1.18

115

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

143

2.68

7.32

2.2

2.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

119

698

1.74

7.32

1.5

1.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

+∞

7.29

1.0

0.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

121

2.83

7.27

1.9

2.3

591.78

482.59

e6/l

0.55

101

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

220

1505

1.50

7.20

3.9

3.4

4.37

4.48

pmol/l

0.98

196

1350

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

242

2.26

7.18

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

302

2.11

7.11

1.7

1.6

—

(3047181) Lactate [Moles/volume] in Blood

123

737

1.70

7.02

6.0

5.6

1.37

1.32

mmol/l

0.22

101

642

(3008295) Osmolality of Serum or Plasma

264

2.18

7.01

1.4

274.77

278.54

mosm/kgh2o

0.59

206

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

421

1.93

6.99

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

233

1627

1.47

6.89

1.2

106.28

148.17

u/ml

1.08

591

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

135

834

1.65

6.87

2.3

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

152

968

1.60

6.85

1.7

0.40

0.33

mg/l

0.71

442

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

216

2.29

6.79

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

112

664

1.72

6.66

2.0

2.50

12.67

iu/l

0.62

268

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

217

1505

1.48

6.65

1.4

1.3

61.15

50.77

au/ml

0.24

107

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1156

10186

1.23

6.60

2.2

1.9

1.45

1.36

mmol/l

2.64

976

8561

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

123

2.70

6.50

1.1

—

(3008898) HLA-B27 [Presence]

125

769

1.66

6.48

1.2

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

273

2.11

6.47

1.2

1.3

103.92

71.38

u/ml

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

208

2.28

6.47

1.6

1.4

20.26

34.09

2.29

124

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

233

1650

1.45

6.42

2.5

2.4

19.28

21.86

au/ml

0.20

158

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

155

2.47

6.27

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

174

2.38

6.22

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

187

2.32

6.18

1.1

—

(3007461) Platelets [#/volume] in Blood

2588

25169

1.57

6.15

39.9

24.0

256.98

250.69

e9/l

4.84

2557

24682

(3014765) Yersinia sp identified in Stool by Organism specific culture

104

619

1.71

6.12

1.3

1.2

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2588

25171

1.57

6.12

39.6

23.9

91.42

91.19

1.57

2572

24911

(3035941) MCH [Entitic mass]

2588

25173

1.57

6.09

39.6

23.9

30.30

30.34

0.66

2571

24911

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2588

25174

1.57

6.08

40.6

24.5

39.82

40.33

5.16

2571

24899

(3026361) Erythrocytes [#/volume] in Blood

2588

25174

1.57

6.08

39.7

24.0

4.42

4.48

e12/l

8.03

2550

24604

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

8.60

6.05

2.1

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

158

2.42

6.03

1.2

—

(3010813) Leukocytes [#/volume] in Blood

2588

25180

1.56

6.00

39.8

24.0

6.98

6.69

e9/l

9.93

2550

24607

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.94

6.00

2.7

1.8

130.75

170.00

umol/l

0.30

(3000012) Reticulocyte production index

344

1.94

5.98

1.9

2.1

0.84

0.90

0.45

240

(3000963) Hemoglobin [Mass/volume] in Blood

2588

25183

1.56

5.96

40.1

24.1

132.65

135.06

g/l

12.66

2572

24924

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

185

2.29

5.88

1.5

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

103

619

1.69

5.87

1.3

1.2

—

(44813793) Dust mix specific IgE antibody measurement

130

2.56

5.87

1.1

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

180

2.30

5.78

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

354

2738

1.34

5.76

1.9

1.8

1.65

1.48

2.58

301

2391

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

206

2.20

5.76

1.6

1.5

289.97

331.11

mu/l

0.78

161

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

187

2.27

5.74

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

144

2.45

5.70

1.3

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

103

625

1.67

5.67

1.3

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

195

2.22

5.63

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

139

2.46

5.61

1.3

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

235

2.10

5.59

3.3

3.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.20

5.59

1.5

1.2

35.63

37.64

g/l

0.18

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

111

691

1.63

5.54

2.0

2.5

217.25

194.88

1.62

106

664

(3036525) Urea [Moles/time] in 24 hour Urine

10.03

5.53

3.7

4.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

251

2.05

5.45

1.4

2.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

179

2.25

5.42

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

173

2.27

5.39

1.4

1.2

3.70

0.64

u/ml

0.53

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

186

2.22

5.38

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

186

2.22

5.38

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.41

5.30

33.3

6.5

6.62

5.43

kpa

0.83

(3044007) Cell count panel - Peritoneal fluid

2.93

5.30

1.5

2.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

3.06

5.22

2.1

2.2

31.05

30.27

0.09

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.76

5.20

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.76

5.20

1.2

1.4

—

(40761536) Microorganisms panel - Urine sediment

256

1914

1.37

5.20

6.0

3.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

176

2.23

5.19

1.7

1.5

1.06

1.31

promille

0.45

136

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

263

2.00

5.18

1.4

1.53

1.43

nmol/l

0.26

235

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

250

2.02

5.14

1.9

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

158

2.30

5.12

1.3

1.5

—

(3036489) Thrombin time

138

923

1.52

5.09

1.8

2.1

20.84

21.15

0.27

130

824

(3033099) Centromere Ab [Titer] in Serum

4.46

5.05

1.1

—

(3042631) Mycobacterium sp identified in Specimen

308

1.90

5.03

3.3

2.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

308

1.90

5.03

1.7

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.71

4.98

1.7

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

3.67

4.92

1.1

1.4

—

(4024509) Urine culture

163

1137

1.46

4.91

2.1

1.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

154

1063

1.48

4.89

1.5

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

173

1222

1.44

4.88

2.6

2.4

—

(3023419) Bacteria identified in Sputum by Culture

313

1.87

4.81

3.4

2.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

113

733

1.57

4.80

2.1

2.6

3.83

3.60

g/l

0.92

106

700

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

860

0.52

4.80

1.1

1.2

1.50

1.55

g/l

0.60

860

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

230

2.02

4.75

2.0

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

803

0.50

4.73

1.1

0.75

0.64

ratio

—

115

(3017704) Immunofixation for Urine

145

2.29

4.70

1.5

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

130

879

1.50

4.59

1.6

17.66

16.40

u/ml

0.08

198

(3040151) Glucose [Moles/volume] in Capillary blood

255

1.94

4.54

6.4

5.3

8.16

7.25

mmol/l

0.76

214

(44790048) Parainfluenza type 2 nucleic acid detection

327

1.82

4.52

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

327

1.82

4.52

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

327

1.82

4.52

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

327

1.82

4.52

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

118

2.39

4.39

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

118

2.39

4.39

1.6

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

118

2.39

4.39

1.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

118

2.39

4.39

1.6

1.5

—

(3022313) Gas panel - Capillary blood

153

1079

1.44

4.38

5.7

3.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

203

2.04

4.38

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

203

2.04

4.38

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

203

2.04

4.38

1.6

1.5

—

(3011985) Renin [Units/volume] in Plasma

360

1.77

4.38

1.5

1.4

60.29

52.27

mu/l

0.12

323

(3027923) C peptide [Moles/volume] in Serum or Plasma

157

2.18

4.34

1.2

1.4

1.47

1.22

nmol/l

0.55

115

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

347

1.78

4.31

1.1

1.52

1.51

g/l

0.09

317

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

304

1.83

4.27

1.8

1.3

—

(3045424) Erythrocytes [Presence] in Urine

163

1172

1.42

4.21

2.8

2.2

0.00

0.71

estimate

0.51

361

(3024522) Salmonella sp identified in Specimen by Organism specific culture

306

1.81

4.19

1.8

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.27

4.18

1.1

1.5

1.15

1.17

mmol/l

0.32

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

228

1.95

4.16

3.5

2.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

567

1.59

4.13

1.7

1.4

13.35

10.27

u/l

1.00

453

(3045414) Leukocytes [Presence] in Urine

297

2349

1.30

4.13

2.5

2.1

0.00

0.02

estimate

1.06

486

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

209

1.98

4.06

1.6

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.64

4.06

1.5

2.1

120837.00

2260.12

e6/l

—

(3019225) pH of Specimen

292

2310

1.30

4.06

5.4

4.3

7.37

7.35

1.04

225

1649

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

268

2097

1.31

4.04

2.4

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.35

4.04

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

288

1.82

4.03

1.8

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

141

997

1.44

4.01

1.4

30.34

30.30

iu/l

0.00

122

850

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

290

1.81

3.95

1.8

1.4

—

(3012441) Differential panel - Pleural fluid

254

1.87

3.94

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

240

1.89

3.93

1.4

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

112

2.33

3.92

1.2

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

215

1638

1.34

3.91

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

291

1.80

3.91

1.8

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.46

3.88

1.5

2.4

7211.80

771.60

e6/l

0.44

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.51

3.88

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.51

3.88

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.51

3.88

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

139

2.17

3.83

1.2

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

214

1.93

3.82

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

3.07

3.80

1.1

1.3

—

145.75

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

339

2756

1.26

3.79

10.0

6.6

—

(3016750) Collection duration of Urine

140

2.16

3.77

2.5

2.2

506.10

487.83

min

0.43

104

(3022493) Free Hemoglobin [Mass/volume] in Plasma

102

2.36

3.74

1.2

7.0

56.61

64.89

mg/l

0.36

(3006653) Thiamine [Moles/volume] in Blood

141

2.14

3.71

1.2

139.63

135.61

nmol/l

0.17

141

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

379

1.68

3.70

1.5

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

267

1.81

3.70

1.5

1.3

40107.55

89331.08

e6/l

0.75

147

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

244

1910

1.30

3.68

2.3

1.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

665

1.51

3.67

1.4

1.3

—

(3039000) Anion gap in Blood by calculation

507

1.57

3.60

7.1

6.5

12.06

11.29

mmol/l

1.31

446

(3018572) Chloride [Moles/volume] in Blood

508

1.57

3.57

7.1

6.5

103.94

105.26

mmol/l

1.51

447

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

7.79

3.56

4.3

3.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.51

3.54

3.8

2.1

237.50

35736.57

u/ml

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

193

2503

0.75

3.54

2.0

3.81

3.48

ratio

1.93

138

1960

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

131

2.15

3.51

1.2

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

600

1.52

3.48

1.2

1.1

2.50

4.21

—

(21494755) Public health laboratory ask at order entry panel

153

2046

0.73

3.46

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

133

2.12

3.39

1.2

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

231

1.83

3.38

3.1

3.3

13.81

12.13

index

0.43

132

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

678

1.48

3.37

1.2

1.3

193.19

207.46

miu/ml

0.13

302

(3024891) Influenza virus A+B Ag [Presence] in Specimen

580

1.52

3.37

1.2

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

7.01

3.36

7.0

5.3

437.43

386.30

umol/l

—

(3000093) Morphology [Interpretation] in Blood Narrative

217

1.86

3.36

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.94

3.28

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.51

3.21

1.1

1.5

12.62

12.72

g/l

0.01

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.18

3.19

1.2

1.1

97.60

95.58

—

(3046861) Legionella sp Ag [Presence] in Urine

6.38

3.18

1.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

151

2.00

3.14

2.2

2.0

15.57

15.90

0.06

145

(3032057) Clostridioides difficile [Presence] in Stool

3.26

3.13

1.8

2.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.96

3.13

2.2

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

429

0.46

3.11

1.5

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.38

3.06

1.3

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

269

1.72

3.05

2.2

1.9

3920.00

1636.36

titre

—

(3006245) CD3-CD19+ cells/cells in Blood

2.51

3.04

2.4

2.3

11.47

10.68

0.12

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

339

1.64

3.01

1.4

1.3

368.80

317.97

pmol/l

0.42

290

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

115

830

1.40

3.00

5.5

3.8

24.72

25.00

mmol/l

0.42

103

770

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

10.01

2.98

1.2

6.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

10.01

2.98

1.0

3.2

—

(3004775) Volume in Urine collected for unspecified duration

183

1.87

2.96

2.5

2.3

641.26

617.81

0.12

124

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

101

2.19

2.93

2.0

3.8

2.14

1.11

0.65

101

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

115

2.10

2.88

1.2

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

115

2.10

2.88

1.2

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

244

1.73

2.87

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2021

19416

1.16

2.85

33.5

20.3

331.10

332.07

g/l

4.94

2015

19305

(3023199) Leukocytes [#/volume] in Pleural fluid

313

1.64

2.85

1.6

1.4

2419.08

1812.03

e6/l

0.31

221

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

3.17

2.85

7.3

7.5

9.78

10.55

0.53

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.30

2.84

2.7

2.6

0.58

0.61

mmol/l

1.31

(3045683) HLA typing for celiac disease panel - Blood or Tissue

124

2.03

2.76

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

152

1.92

2.75

2.0

1.8

92.86

112.33

ng/l

0.56

152

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

332

1.61

2.75

1.2

1.1

0.93

3.77

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

141

1840

0.75

2.74

1.8

1.7

3.47

3.49

mmol/l

0.06

1287

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

104

2.12

2.74

2.1

1.5

26.75

29.39

umol/l

0.69

(3003434) Protein [Mass/volume] in Pleural fluid

341

1.60

2.71

1.5

30.72

32.55

g/l

0.43

304

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

211

1.76

2.71

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

281

1.65

2.64

1.3

32.10

29.60

u/l

0.19

230

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

191

1.79

2.62

1.1

1.2

193.33

133.51

titre

—

(3023511) Choriogonadotropin [Units/volume] in Urine

290

1.63

2.60

1.6

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

199

1.77

2.60

1.2

114.09

106.34

pmol/l

0.26

199

(3025549) Creatine [Moles/time] in 24 hour Urine

4.68

2.59

1.7

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

124

933

1.34

2.55

2.7

1.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

180

1.79

2.47

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

496

1.46

2.47

1.9

2.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

681

1.39

2.45

2.0

1.7

288.36

298.65

mu/l

0.11

617

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

5.01

2.40

2.2

1.5

206.67

540.73

nmol/l

—

(21491868) Cryoglobulin [Mass/volume] in Serum

2.22

2.37

1.1

1.2

—

0.14

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

6.26

2.37

1.0

1.9

2.01

1.66

nmol/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

307

1.57

2.33

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.95

2.28

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.95

2.28

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.95

2.28

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

141

1.85

2.27

2.4

2.8

37.58

40.82

0.41

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.62

2.27

1.3

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

342

1.53

2.25

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

399

1.49

2.24

1.4

1.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.28

2.24

1.3

1.2

0.37

0.29

g/l

—

(3004451) EKG impression Narrative

149

1.82

2.24

1.8

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

359

1.51

2.22

1.5

1.2

2.83

4.81

u/ml

1.27

164

(4035726) Immunohistochemistry procedure

256

2146

1.21

2.22

1.5

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

219

1.65

2.15

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.29

2.15

1.2

1.1

—

(3001729) Color of Synovial fluid

3.69

2.15

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.69

2.15

1.6

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

428

1.46

2.14

1.4

1.2

20.41

36.60

u/l

1.43

366

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

189

1.70

2.13

1.6

1.2

2.96

2.04

mmol/l

0.42

176

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

588

1.39

2.13

2.8

2.1

8941.96

5510.72

u/l

0.26

250

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

3.51

2.05

2.1

1.9

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.51

2.05

2.0

3.0

0.67

0.58

ug/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

104

1.93

2.00

4.5

4.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

411

1.45

1.97

1.1

43.33

1489.83

iu/ml

0.52

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

3.34

1.96

1.6

1.7

26.61

23.89

mg/l

—

(4268621) Lupus anticoagulant assay

257

1.56

1.95

2.7

2.3

—

(3045142) Bone marrow Pathology biopsy report

265

1.56

1.95

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

364

1.47

1.91

1.5

1.2

3.94

3.86

u/ml

0.02

132

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

144

1156

1.26

1.90

2.7

2.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.96

1.90

1.1

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

166

1.69

1.87

1.3

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.09

1.86

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

850

9139

0.90

1.85

3.5

3.2

—

(3045788) Cell count panel - Pleural fluid

261

1.54

1.84

1.6

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.21

1.84

1.3

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.06

1.80

1.1

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.01

1.80

1.6

1.5

99.44

154.05

nmol/24h

0.27

(40768806) Pleura Pathology biopsy report

255

1.54

1.79

1.7

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

154

1.69

1.76

1.8

1.5

81.42

83.80

umol/l

0.14

154

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.34

1.74

1.2

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

117

1.80

1.74

1.0

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.85

1.71

101.2

3.8

106.00

104.92

g/l

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.85

1.71

1.4

1.5

257.20

324.85

umol/24h

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

3.85

1.71

3.6

2.3

2.64

2.35

mg/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

144

1177

1.24

1.66

1.1

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

157

1.66

1.65

2.4

2.1

7.90

8.55

mmol/l

0.39

157

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

252

1.52

1.65

3.5

3.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.10

1.65

1.2

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.10

1.65

1.2

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.58

1.61

1.0

—

(40758292) HTLV I+II Ab panel - Serum

2.39

1.61

1.2

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

166

1.63

1.61

1.4

2.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.50

1.59

1.1

1.2

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

2.50

1.59

1.0

1.2

—

mmol/l

—

(3011897) Casein IgE Ab [Units/volume] in Serum

3.00

1.58

1.3

1.1

0.04

0.02

u/ml

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.70

1.58

1.4

1.3

—

640.53

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.86

1.50

2.7

0.50

0.52

u/field

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

697

1.29

1.49

1.4

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.00

1.48

1.2

1.5

31.19

25.01

g/l

—

(3010838) Calcium [Moles/time] in 24 hour Urine

445

1.36

1.47

1.8

1.9

3.89

5.13

mmol/24h

2.95

388

(3027456) Digoxin [Moles/volume] in Serum or Plasma

481

1.34

1.45

3.8

3.5

0.95

0.81

nmol/l

0.71

395

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

542

1.32

1.44

2.1

3.5

50.20

990.12

u/ml

1.24

500

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.88

1.44

1.2

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.12

1.44

1.4

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.04

1.43

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

517

1.32

1.43

1.4

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

303

1.43

1.42

1.7

2.7

—

(3022621) pH of Urine by Test strip

224

1941

1.17

1.42

3.0

2.6

6.00

6.07

0.54

153

1324

(3043238) Trisomy 21 risk [Likelihood] in Fetus

314

0.60

1.41

1.2

1.6

—

(3024263) Appearance of Synovial fluid

118

1.70

1.41

1.2

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

189

1.54

1.40

2.2

2.0

1.41

1.70

u/field

0.17

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

330

1.40

1.39

2.3

2.5

16.39

172.64

u/ml

0.68

323

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

111

1.72

1.39

2.7

1.7

0.77

2.49

u/field

2.38

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

111

1.72

1.39

1.5

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.61

1.36

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.94

1.36

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.94

1.36

7.8

7.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

637

1.28

1.34

1.5

1.2

627.73

538.01

mg/l

0.39

606

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

291

1.42

1.32

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

498

1.31

3.8

3.6

27.14

26.16

mg/l

0.07

341

(40768441) Liver Pathology biopsy report

193

1.51

1.29

1.0

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

306

0.62

1.29

1.2

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

553

1.29

1.28

1.4

1.3

67.02

30.89

e6/l

0.30

406

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

625

1.27

1.26

1.4

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.40

1.24

1.5

1.9

—

(3051101) Glucose [Moles/volume] in Cord blood

2.23

1.24

3.5

6.4

9.38

8.48

mmol/l

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.91

1.22

1.1

—

(40757373) Influenza virus identified in Isolate

2.04

1.22

1.7

1.4

—

(3005033) Fetal Nuchal fold Thickness US

300

0.63

1.20

1.2

1.4

1.03

1.28

—

203

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.83

1.19

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

561

1.27

1.17

1.5

1.3

4783.13

1268.63

e6/l

0.42

437

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

555

1.27

1.13

1.5

1.2

4.23

3.78

mmol/l

1.65

528

(3016879) Cocaine [Presence] in Urine

663

1.24

1.12

1.7

2.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.34

1.12

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

556

1.27

1.11

4.1

4.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

399

0.70

1.10

1.2

1.5

84.87

61.95

ug/l

0.60

322

(3001019) Free T4 and TSH panel - Serum or Plasma

1146

0.82

1.09

1.9

1.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

160

1.50

1.09

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.73

1.09

1.1

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

769

7266

1.08

1.07

5.2

5.4

2.25

2.80

ug/l

1.17

694

6590

(1001926) Buprenorphine [Presence] in Urine by Screen method

577

1.25

1.07

1.8

2.0

—

(3038515) Glucose [Moles/volume] in Venous blood

497

1.27

1.07

3.2

7.25

7.56

mmol/l

0.45

478

(3047189) Immunofixation for 24 hour Urine

121

1.57

1.05

1.2

1.8

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.79

1.04

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.79

1.04

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.79

1.04

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.79

1.04

1.0

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.96

1.03

1.1

1.0

—

(3027944) Amphetamines [Presence] in Urine

716

1.22

1.03

1.6

1.9

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.84

1.02

1.0

1.1

95.20

87.24

—

(3035320) C reactive protein [Mass/volume] in Body fluid

188

1.44

1.01

4.2

2.6

31.72

30.53

mg/l

0.05

130

(3009466) Valproate [Moles/volume] in Serum or Plasma

325

1.33

1.00

5.0

5.6

311.71

360.96

umol/l

1.06

287

(3003694) ABO and Rh group [Type] in Blood

723

6837

1.08

0.99

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

367

0.71

0.99

1.2

1.5

1.05

1.18

ratio

0.24

222

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

367

0.71

0.99

1.2

1.5

1.27

1.12

ratio

0.23

222

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

367

0.71

0.99

1.2

1.5

0.87

0.95

ratio

0.51

222

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.81

0.98

1.0

1.2

97.40

85.34

—

(3028300) Cannabinoids [Presence] in Urine

730

1.21

0.98

1.6

2.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.95

0.97

1.0

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

722

1.21

0.97

1.6

2.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

116

1.56

0.96

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.74

0.96

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

805

1.20

0.96

1.4

—

(3005570) Glucose [Moles/volume] in Urine

250

1.36

0.95

1.9

2.0

—

(4195642) Thrombophilia screening test

337

1.31

0.95

1.2

—

(3027008) Opiates [Presence] in Urine

724

1.21

0.94

1.6

2.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

2.22

0.93

1.0

11.80

17.39

g/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

362

0.72

0.92

1.2

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

383

1.28

0.92

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

389

3596

1.10

0.92

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.15

0.91

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.15

0.91

1.5

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

385

1.28

0.89

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.07

0.89

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

359

1.29

0.88

1.2

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

119

1.52

0.88

1.1

—

(4198724) Urine methamphetamine measurement

1.65

0.88

1.5

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

139

0.57

0.83

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

213

1923

1.12

0.82

2.6

2.4

12.52

13.15

nmol/l

0.49

191

1733

(40768795) Lymph node Pathology biopsy report

241

1.33

0.80

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

356

1.27

0.80

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

409

4375

0.92

0.79

3.0

3.3

0.67

0.76

ug/l

1.27

281

2850

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

106

1.51

0.78

2.9

2.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

210

0.66

0.77

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

157

1.40

0.76

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.77

0.76

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

0.74

1.2

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

436

0.78

0.74

5.1

4.0

33.45

30.88

u/ml

0.11

424

(4015189) Microbial culture of sputum

1.64

0.73

1.9

2.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.00

0.72

1.8

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

285

2633

1.09

0.72

3.2

4.3

4.22

19.40

ug/l

3.97

236

2144

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

134

1.42

0.71

1.1

0.90

1.17

u/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

182

0.66

0.70

1.2

—

(3022689) Creatine [Moles/volume] in Urine

1.56

0.68

1.2

1.4

7.88

8.72

mmol/l

0.25

(3014271) Vancomycin [Susceptibility]

102

1.47

0.67

3.3

2.7

—

(40768800) Prostate Pathology biopsy report

473

0.80

0.66

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.54

0.65

7.6

2.8

5.25

4.90

kpa

0.37

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.54

0.65

7.6

2.8

10.80

10.35

kpa

0.09

(3002256) Pathology report gross observation

354

3319

1.08

0.64

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

287

1.26

0.63

1.3

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

813

1.15

0.63

1.6

1.8

10.63

4.24

mg/l

0.54

601

(21494814) CD8 cells/Lymphocytes in Specimen

1.50

0.63

2.1

1.8

26.77

29.38

0.24

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.67

0.61

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.61

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.54

0.59

6.1

2.5

14.75

5.00

ug/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.59

0.0

2.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

680

0.85

0.58

1.3

1.6

1068.95

976.96

mu/l

0.23

557

(21494434) Karyotype in Bone marrow

202

1.29

0.57

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.67

0.56

1.2

63.33

66.72

ug/l

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.67

0.56

1.2

1.6

1.55

263340.44

nmol/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

115

1.39

0.56

1.5

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

150

1.34

0.55

1.5

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.62

0.55

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

321

1.22

0.54

1.4

1.3

—

nmol/l

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.50

0.54

1.4

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.42

0.54

1.5

1.7

37.51

40.05

g/l

0.63

(3024869) Neuronal Ab [Presence] in Serum

1.50

0.51

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.50

0.51

1.8

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

333

1.20

0.51

1.4

1.3

0.16

0.24

nmol/l

0.83

265

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

201

0.74

0.49

2.1

1.6

1.13

4.47

ug/l

—

172

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

420

1.17

0.47

2.1

1.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

319

1.19

0.46

1.8

1.5

0.18

0.32

nmol/l

2.11

231

(3023383) Lactate [Moles/volume] in Pleural fluid

1.43

0.41

1.4

1.5

2.78

2.88

mmol/l

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.52

0.41

4.8

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(4133840) Spirometry

1.36

0.41

1.5

1.2

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

32.86

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

25.17

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

114

1.32

0.40

2.5

2.1

10.00

201.30

ug/min

—

(3017569) Oxygen content in Arterial blood

150

1.27

0.40

2.5

2.3

15.90

16.39

0.31

150

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

104

0.67

0.39

1.4

1.2

12.57

9.11

mm/h

—

104

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.43

0.39

1.6

1.3

73.34

88.06

ng/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

205

1.22

0.39

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.36

0.38

1.2

1.1

—

(1002224) Polysomnography panel

124

1145

1.09

0.38

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.37

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.29

0.36

2.7

1.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

162

1.24

0.35

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.37

0.34

1.2

14.99

16.65

umol/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

145

1.24

0.33

1.2

1.4

165.31

223.07

pmol/l

0.39

145

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

136

1.25

0.33

1.3

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

712

1.10

0.32

1.1

—

(4034850) Laboratory test

732

1.10

0.32

9.6

9.9

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.30

0.30

2.0

1.4

0.57

0.45

e9/l

—

(40765096) Chromosome analysis panel by Banding

1.33

0.30

1.4

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

111

1.26

0.30

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

213

1.18

0.29

3.1

2.9

60.42

34.05

mg/l

0.21

156

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

176

1.19

0.28

1.2

1.1

35.00

43.26

mg/l

0.62

143

(3050129) First trimester maternal screen panel - Serum or Plasma

438

0.89

0.27

1.3

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

599

5848

1.03

0.26

4.7

4.5

21.30

21.75

0.30

267

2860

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

330

0.88

0.25

1.4

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

283

1.13

0.24

2.1

2.3

27.36

21.03

mg/l

0.45

107

(3028679) Herpes simplex virus Ab [Presence] in Serum

124

1.21

0.24

1.1

—

(40768793) Breast Pathology biopsy report

609

0.92

0.23

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.32

0.23

1.2

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

116

1.21

0.22

1.2

1.4

6.07

5.98

mmol/l

0.07

109

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.5

—

0.15

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(4281824) Cell count and differential, peritoneal fluid

283

0.88

0.21

1.1

—

(3000330) Specific gravity of Urine by Test strip

129

1229

1.05

0.20

3.6

3.4

1.02

ratio

0.75

120

1116

(3024666) Lithium [Moles/volume] in Serum or Plasma

123

0.81

0.20

7.6

13.1

0.65

0.64

mmol/l

—

116

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.25

0.20

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.24

0.18

1.2

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.17

0.17

1.0

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.72

0.17

1.2

1.4

20.06

27.99

nmol/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

120

0.83

0.16

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.18

0.16

1.3

1.0

—

(3034426) Prothrombin time (PT)

0.76

0.15

1.3

26.50

29.34

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

214

2201

0.97

0.15

1.5

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

296

0.91

0.14

2.0

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

296

2894

1.03

0.14

4.9

5.0

30.95

32.44

1.66

210

1897

(4027681) Cerebrospinal fluid IgG ratio and IgG index

132

1.14

0.13

1.4

1.3

0.52

0.57

ratio

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

394

1.07

0.12

1.1

16.16

15.46

au/ml

—

(4146454) Self-monitoring of blood glucose

269

1.08

0.11

2.6

2.5

—

(3023410) Appearance of Cerebral spinal fluid

250

1.08

0.11

1.4

1.3

—

(4211845) Urine protein measurement

115

0.87

0.10

3.5

2.9

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.11

0.09

1.4

2.2

22.24

19.08

umol/l

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

232

1.08

0.09

4.6

5.5

207.79

41.71

u/ml

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.09

0.09

3.0

2.0

—

(3000285) Sodium [Moles/volume] in Blood

1.07

0.08

1.3

1.2

136.33

138.91

mmol/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

113

0.88

0.08

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

224

1.07

0.08

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

156

1.09

0.08

1.1

21.02

17.60

u/ml

—

(44806420) Estimation of glomerular filtration rate

266

0.94

0.07

3.0

2.4

—

(3020650) Glucose [Presence] in Urine

1.05

0.07

2.6

2.1

0.33

0.03

estimate

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.87

0.06

1.1

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

100

1.10

0.05

1.5

1.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

241

1.04

0.02

1.3

1.6

58.63

57.97

ug/l

0.02

241

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

232

1.03

0.02

1.1

—

(3006462) Nitrate [Presence] in Urine

107

0.93

0.02

3.5

3.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

132

1313

1.01

0.00

2.6

3.7

32.96

72.62

u/ml

2.38

126

1270

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

154

1.04

0.00

6.8

7.1

27.96

143.47

ug/l

0.50

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

216

0.97

0.00

1.2

1.3

—

(3025130) Human papilloma virus identified in Specimen

349

1.00

0.00

2.1

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

947

1.00

0.00

2.9

3.5

137.71

3488.76

u/ml

0.66

815

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

330.83

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

5.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.02

-0.00

1.0

1.6

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

3.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1308.00

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

227.67

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_LICHSIMPANDPRURIGO and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_LICHSIMPANDPRURIGO	1.42 [1.28, 1.58]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.288

During the follow-up period (1.1.1998 — 31.12.2019), 1395 out of 7396 females with L12_LICHSIMPANDPRURIGO died.

Males

Parameter	HR [95% CI]	p-value
L12_LICHSIMPANDPRURIGO	1.511 [1.36, 1.68]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.018

During the follow-up period (1.1.1998 — 31.12.2019), 1474 out of 6002 males with L12_LICHSIMPANDPRURIGO died.

Mortality risk

Mortality risk for people of age

years, who have L12_LICHSIMPANDPRURIGO.

N-year risk	Females	Males
1	0.126%	0.335%
5	0.773%	1.944%
10	1.863%	4.649%
15	3.905%	8.447%
20	7.104%	14.341%

Relationships between endpoints

↥

Index endpoint: L12_LICHSIMPANDPRURIGO – Lichen simplex chronicus and prurigo

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Lichen simplex chronicus and prurigo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints